Persons encountering health services for examination and investigation

Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Z00-Z13 Cause of death: ICD-10 — Z00-Z13 2 out of 7 registries used, show all original rules.	311782
4. Check minimum number of events None	311782
5. Include endpoints Z21_GENERAL_EXAM_INVES_PERSONS_WO_COMPLA_REPOR_DIAGNOSIS Z21_OTHER_SPECIAL_EXAM_INVES_PERSONS_WO_COMPLA_REPOR_DIAGNOSIS Z21_EXAM_ENCOUNTER_ADMINISTR_PURPO Z21_MEDICAL_OBSER_EVALU_SUSPECTED_DISEA_CONDI Z21_EXAM_OBSER_OTH_REASO Z21_FOLLOW__EXAM_TREAT_MALIG_NEOPLASMS Z21_FOLLOW__EXAM_TREAT_CONDI_OTH_MALIG_NEOPLASMS Z21_ROUTI_GENERAL_HEALTH_CHECK_DEFIN_SUBPO Z21_SPECIAL_SCREEN_EXAM_INFECTIOUS_PARASITIC_DISEA Z21_SPECIAL_SCREEN_EXAM_NEOPLASMS Z21_SPECIAL_SCREEN_EXAM_OTH_DISEA_DISORD	311782
6. Filter based on genotype QC (FinnGen only)	280224

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Z

NAME	Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	Z21_GENERAL_EXAM_INVES_PERSONS_WO_COMPLA_REPOR_DIAGNOSIS\|Z21_OTHER_SPECIAL_EXAM_INVES_PERSONS_WO_COMPLA_REPOR_DIAGNOSIS\|Z21_EXAM_ENCOUNTER_ADMINISTR_PURPO\|Z21_MEDICAL_OBSER_EVALU_SUSPECTED_DISEA_CONDI\|Z21_EXAM_OBSER_OTH_REASO\|Z21_FOLLOW__EXAM_TREAT_MALIG_NEOPLASMS\|Z21_FOLLOW__EXAM_TREAT_CONDI_OTH_MALIG_NEOPLASMS\|Z21_ROUTI_GENERAL_HEALTH_CHECK_DEFIN_SUBPO\|Z21_SPECIAL_SCREEN_EXAM_INFECTIOUS_PARASITIC_DISEA\|Z21_SPECIAL_SCREEN_EXAM_NEOPLASMS\|Z21_SPECIAL_SCREEN_EXAM_OTH_DISEA_DISORD
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Z[0-1]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Z[0-1]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Persons encountering health services for examination and investigation based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	280224	171899	108325
Unadjusted period prevalence (%)	56.64	61.03	49.67
Median age at first event (years)	51.55	47.79	57.52

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
45585: Matched controls
228577

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

5.4

320.7

864

819

SPAT1263

SPAT

Sampling

1.5

320.6

15170

56335

A02BC03

ATC

lansoprazole; oral

1.6

319.8

9424

31293

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

314.9

6082

17911

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

308.3

7475

23526

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

307.7

11474

38624

N05AH04

ATC

quetiapine; oral

2.2

307.7

6855

17310

A02BC05

ATC

esomeprazole; systemic

1.7

307.7

14521

50240

AA1AD

NOMESCO Finland

CT of head and brain

1.8

307.7

9903

30580

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

25.4

307.7

1211

245

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

307.7

14329

44751

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

307.7

20999

82500

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

17.3

307.7

1952

590

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

307.7

15984

58695

R06.0

ICD-10 Finland

Dyspnoea

1.9

307.7

9649

28362

J01DB01

ATC

cefalexin; oral

1.8

307.7

34719

145847

DFF15

NOMESCO Finland

Speech audiometry

5.4

307.7

1482

1409

N02BE01

ATC

paracetamol; systemic, rectal

2.0

307.7

37743

160451

XQ802

NOMESCO Finland

Epicutan test

6.1

307.7

1254

1059

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.6

307.7

10994

25276

S18

ICPC

Laceration/cut

1.7

307.7

17326

61179

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

584.1

307.7

3841

N06AX11

ATC

mirtazapine; oral

1.8

307.7

12788

41048

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

2.9

307.7

5642

10543

N05CF01

ATC

zopiclone; oral

1.6

307.7

11245

38576

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.9

307.7

1724

2256

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

4.7

307.7

2199

2427

A04

ICPC

Weakness/tiredness general

1.9

307.7

5754

15924

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.2

307.7

4364

10401

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

307.7

10703

35687

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

12.8

307.7

5743

2551

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

11.5

307.7

1510

680

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.7

307.7

3428

6709

L17

ICPC

Foot/toe symptom/complaint

1.6

307.7

10655

36209

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.2

307.7

4776

11602

Z00.0

ICD-10 Finland

General medical examination

3.5

307.7

7994

13151

UJF30

NOMESCO Finland

Ileoscopy through colon

2.6

307.7

3438

7077

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

6.0

307.7

5635

5267

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

23.0

307.7

2400

551

C07AB07

ATC

bisoprolol; oral

1.6

307.7

17126

61855

Z97.4

ICD-10 Finland

Presence of external hearing-aid

5.6

307.7

1614

1493

SPAT1216

SPAT

Assessment of functional ability

2.1

307.7

4811

12018

Z01.8

ICD-10 Finland

Other specified special examinations

10.2

307.7

10828

6758

RD211, ,

NOMESCO Finland

4.2

307.7

1233

1491

DFF00

NOMESCO Finland

Pure tone audiometry

4.1

307.7

3481

4556

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

25.8

307.7

3102

645

Z3231

NOMESCO Finland

Registered nurse

1.8

307.7

9769

29491

M25.5

ICD-10 Finland

Pain in joint

1.6

307.7

11675

40560

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

307.7

8029

24975

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

36.5

307.7

540

R42

ICD-10 Finland

Dizziness and giddiness

1.8

307.7

7946

23716

J01MA02

ATC

ciprofloxacin; systemic

1.6

307.7

13880

50057

XQ800

NOMESCO Finland

Prick test

4.5

307.7

2536

2978

UJF32

NOMESCO Finland

Coloscopy

2.3

307.7

9209

23000

Z01.1

ICD-10 Finland

Examination of ears and hearing

9.6

307.7

6234

3692

N03AX12

ATC

[U] gabapentin; oral

2.2

307.7

5276

12787

R03AC02

ATC

salbutamol; inhalant

1.6

307.7

21233

80891

XCK10

NOMESCO Finland

Photography of fundus of eye

3.0

307.7

2999

5291

R51.80

ICD-10 Finland

Headache

2.1

307.7

5591

14270

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

2.0

307.7

5745

15499

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

41.7

307.7

535

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

307.7

8635

27909

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

307.7

16139

58794

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

307.7

10037

29730

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

50.5

307.7

1063

108

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

307.7

8344

25822

N03AX16

ATC

[U] pregabalin

2.0

307.7

7791

21099

N02AX02

ATC

tramadol; systemic, rectal

1.7

307.7

15885

55294

N05BA04

ATC

oxazepam; oral

1.7

307.7

9371

29576

L03

ICPC

Low back symptom/complaint

1.6

307.7

10372

34837

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

307.7

29020

121225

XA402

NOMESCO Finland

ENMG

8.2

307.7

713

442

N06AX16

ATC

venlafaxine; oral

2.0

307.7

4860

12645

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

307.7

9239

29247

Z01.0

ICD-10 Finland

Examination of eyes and vision

20.1

307.7

8294

2502

Z04.3

ICD-10 Finland

Examination and observation following other accident

51.2

307.7

634

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

307.7

14765

53304

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

112.1

307.7

2355

111

L28

ICPC

Limited function/disability (L)

1.9

307.7

6156

17016

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

12.6

307.7

812

328

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.7

307.7

2863

5503

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

307.7

15537

56057

R53

ICD-10 Finland

Malaise and fatigue

1.7

307.7

9574

30175

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

307.7

6522

18621

Z00.8

ICD-10 Finland

Other general examinations

3.2

307.7

2841

4691

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

84.5

307.7

2682

169

Z71.8

ICD-10 Finland

Other specified counselling

1.7

307.7

12910

43043

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

8.5

307.7

8332

5853

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

3.0

307.7

1883

3226

M79.6

ICD-10 Finland

Pain in limb

1.6

307.7

16369

58304

H02AB06

ATC

prednisolone; systemic

1.7

307.7

17993

63669

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.4

307.7

2896

6200

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

307.7

17583

59278

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

21.6

307.7

528

124

-1, ,

NOMESCO Finland

1.6

307.7

12347

43085

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.3

307.7

3031

6779

M54.5

ICD-10 Finland

Low back pain

1.6

307.7

13627

47153

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

307.7

13642

48833

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

4.6

307.7

2043

2317

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

37.4

307.7

4404

652

J01AA02

ATC

doxycycline; systemic

1.5

307.7

30449

129780

N06AX21

ATC

duloxetine; oral

2.2

307.7

3919

9309

A02BC02

ATC

pantoprazole; systemic

1.8

307.7

27037

101465

E0000UV, ,

ATC

1.5

302.5

15483

58279

KMAK, ,

NOMESCO Finland

1.5

301.4

19149

75315

XCK00

NOMESCO Finland

Perimetry

2.9

301.2

1763

3093

C03CA01

ATC

furosemide; systemic

1.6

300.7

10160

34829

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

299.9

17296

66695

N06AB04

ATC

citalopram; systemic

1.7

296.5

6904

21458

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

295.6

4246

11308

UKC02

NOMESCO Finland

Cystoscopy

1.9

295.1

5187

14800

SPAT1301

SPAT

No procedures

1.6

295.0

10750

37492

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

294.8

28648

122216

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.4

293.9

2629

5768

N06AB10

ATC

escitalopram; oral

1.7

292.7

7348

23313

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

288.7

4554

12528

XF402

NOMESCO Finland

ECG with work load test

2.2

287.9

2979

6973

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

4.0

284.3

1049

1332

J01CA04

ATC

amoxicillin; systemic

1.5

281.8

33962

150537

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.0

279.3

3774

9820

N03AX09

ATC

lamotrigine; oral

3.0

279.1

1585

2729

A10AB05

ATC

insulin aspart; parenteral

2.4

278.4

2481

5430

P01AB01

ATC

metronidazole; oral, rectal

1.5

277.2

13797

51397

G47.3

ICD-10 Finland

Sleep apnoea

1.6

275.7

7903

25926

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.3

275.3

2673

6082

XCH00

NOMESCO Finland

Eye pressure measurement

3.3

274.9

1322

2045

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

272.2

10570

37289

A28

ICPC

Limited function/disability NOS

1.8

272.1

5492

16334

SPAT1254

SPAT

Administration of medicine

1.8

271.7

4991

14418

A10AE04

ATC

insulin glargine; parenteral

2.1

271.6

3087

7508

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

271.2

4671

13217

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

267.1

14261

53797

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.7

266.3

1799

3423

XF404

NOMESCO Finland

Ambulatory ECG

2.3

265.8

2549

5766

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

265.5

6676

21133

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

265.2

2163

4536

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

264.5

7758

25568

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

263.4

10521

37305

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

3.6

263.2

1108

1559

A29

ICPC

General symptom/complaint other

1.9

261.5

4400

12346

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

261.4

6883

22050

R05

ICPC

Cough

1.6

261.3

8584

29082

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

260.8

10578

37621

R01AD09

ATC

mometasone; nasal

1.4

257.6

16611

64889

B01AB05

ATC

enoxaparin; parenteral

1.5

256.1

10137

35832

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

255.4

19983

80868

C07AA05

ATC

propranolol; systemic

1.7

254.8

6759

21682

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

254.4

3227

8188

R06AE07

ATC

cetirizine; oral

1.4

254.1

16063

62468

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

253.8

26537

113088

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

251.8

5765

17759

XG410

NOMESCO Finland

Flow-volume spirometry

3.5

251.5

1103

1599

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

4.8

251.4

764

817

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

3.0

251.2

1405

2395

J02AC01

ATC

fluconazole; systemic

1.5

250.1

12966

48475

SFA10

NOMESCO Finland

One-surface restoration

1.4

249.6

21018

86059

M03BX02

ATC

tizanidine; oral

1.4

248.5

23098

96217

SPAT1310

SPAT

Counselling related to known health issue

1.5

248.2

10716

38561

R5120

NOMESCO Finland

Preparation of an aid

4.3

247.2

828

968

SPAT1153

SPAT

Removal of sutures

1.5

245.7

9915

35146

Z01.2

ICD-10 Finland

Dental examination

1.4

245.0

17485

69409

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

4.2

244.5

849

1024

J01FF01

ATC

clindamycin; systemic

1.5

243.9

9202

32126

N02AA05

ATC

oxycodone; systemic

1.7

243.3

5696

17643

K02.1

ICD-10 Finland

Caries of dentine

1.4

242.5

23119

96555

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

242.4

9672

34184

T89

ICPC

Diabetes insulin dependent

3.1

241.2

1260

2057

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

240.7

13717

52156

Z3229

NOMESCO Finland

Other healthcare associate professional

2.2

239.9

2546

6010

R02

ICPC

Shortness of breath/dyspnoea

1.8

239.3

4290

12268

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

238.0

7325

24358

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

237.8

7409

24712

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

237.4

8844

30760

R50.9

ICD-10 Finland

Fever, unspecified

1.7

237.3

5277

16101

ZX120

NOMESCO Finland

Intravenous

2.1

237.0

2785

6852

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

236.8

5964

18834

Z01.7

ICD-10 Finland

Laboratory examination

1.7

235.7

5678

17713

SPAT1252

SPAT

Overall medication plan or its review

2.5

234.9

1870

3871

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.9

234.2

1355

2357

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

233.9

8484

29318

A01

ICPC

Pain general/multiple sites

2.0

233.5

3138

8126

G44.2

ICD-10 Finland

Tension-type headache

1.8

233.1

4395

12762

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

230.9

3315

8792

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

229.4

4967

15028

L01

ICPC

Neck symptom/complaint

1.7

227.9

5401

16761

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

227.8

8602

29973

N06AB06

ATC

sertraline; oral

1.9

226.6

3791

10591

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.8

226.6

1405

2545

T90

ICPC

Diabetes non-insulin dependent

1.6

225.9

7569

25652

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.9

222.9

1307

2291

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

222.8

5395

16834

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

222.0

8352

29055

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

220.8

3538

9741

M79.1

ICD-10 Finland

Myalgia

1.7

220.7

4930

15039

SFA20

NOMESCO Finland

Two-surface restoration

1.4

220.5

22276

93312

DAX08

NOMESCO Finland

Fitting of hearing aid

2.6

220.0

1535

2968

S29

ICPC

Skin symptom/complaint other

1.6

219.5

6788

22553

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

219.0

9251

32990

P29

ICPC

Psychological sympt/compl other

2.1

218.1

2652

6607

Z09.9

ICD-10 Finland

Follow-up examination after unspecified treatment for other conditions

40.8

217.4

235

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

216.2

2194

5076

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.7

216.1

1440

2715

L08

ICPC

Shoulder symptom/complaint

1.6

215.7

7551

25823

N05AH03

ATC

olanzapine; systemic

2.3

214.8

2073

4692

P03

ICPC

Feeling depressed

1.9

214.4

3568

9943

R11

ICD-10 Finland

Nausea and vomiting

2.0

214.4

2889

7481

Z01.9

ICD-10 Finland

Special examination, unspecified

2.4

214.3

1778

3753

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

4.1

214.2

766

947

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

213.5

21033

87548

D07AC01

ATC

betamethasone; topical

1.4

212.2

12833

49079

ZY010

NOMESCO Finland

Hospital outpatient

2.5

211.9

1644

3357

J01DA01

ATC

[U] cefalexin

1.4

211.8

23390

99144

Z12.1

ICD-10 Finland

Special screening examination for neoplasm of intestinal tract

10.9

211.6

344

160

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.0

211.4

2789

7165

WX290

NOMESCO Finland

Other blockage of nerve

1.4

209.8

18339

74762

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

209.1

7714

26672

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

209.1

7801

27041

N02BF01

ATC

gabapentin; oral

1.9

209.0

3146

8472

D01

ICPC

Abdominal pain/cramps general

1.8

206.4

4115

12129

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

206.4

2938

7757

C10AA01

ATC

simvastatin; oral

1.4

206.3

12900

49581

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.0

205.8

2974

7894

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

205.3

5642

18174

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

203.1

3879

11283

R03DC03

ATC

montelukast; oral

1.7

203.0

5285

16783

S06.0

ICD-10 Finland

Concussion

1.8

202.5

3651

10431

R05

ICD-10 Finland

Cough

1.6

202.3

7090

24211

M01AE02

ATC

naproxen; oral, rectal

1.4

201.0

21157

88674

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

200.4

3216

8846

N06AA09

ATC

amitriptyline; systemic

2.0

199.1

2610

6684

B01AC04

ATC

clopidogrel; oral

1.7

198.6

4778

14850

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

198.5

3472

9822

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.5

198.4

1589

3295

R07.3

ICD-10 Finland

Other chest pain

1.9

198.1

3206

8843

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

197.7

5068

16020

SPAT1240

SPAT

Therapeutic discussion

1.8

196.2

3441

9741

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

195.9

5269

16862

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

195.8

5887

19374

P01

ICPC

Feeling anxious/nervous/tense

1.7

195.0

4618

14286

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

194.9

6686

22700

ZXA00

NOMESCO Finland

Right side

1.5

194.9

8204

29136

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

194.8

2007

4670

M01AH05

ATC

etoricoxib; oral

1.4

193.8

22884

97433

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

193.3

2564

6594

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

193.0

7771

27332

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

192.5

10863

40865

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

190.3

4082

12278

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

190.2

19798

82555

A10AE05

ATC

insulin detemir; parenteral

2.4

189.9

1574

3318

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

189.8

4134

12487

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

4.4

189.0

618

707

K30

ICD-10 Finland

Functional dyspepsia

1.8

188.7

3520

10154

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

187.6

9560

35244

N05CF02

ATC

zolpidem; oral

1.6

187.6

5450

17770

J01EA01

ATC

trimethoprim; systemic

1.5

187.2

8138

29062

M01AC06

ATC

meloxicam; systemic, rectal

1.4

187.2

11637

44515

H13

ICPC

Plugged feeling ear

1.6

186.9

6129

20574

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.1

186.5

1005

1672

R13

ICD-10 Finland

Dysphagia

2.2

185.8

2026

4825

SPAT1097

SPAT

Recording of ECG

1.7

185.6

4077

12341

R01AD08

ATC

fluticasone; nasal

1.4

185.3

9689

35884

C10AA05

ATC

atorvastatin; oral

1.4

185.3

13493

53035

A06AD11

ATC

lactulose; oral

1.7

184.2

4732

14947

J01MA12

ATC

levofloxacin; systemic

1.6

183.9

5852

19498

N03AG01

ATC

valproic acid; systemic, rectal

2.2

183.7

1821

4165

J01FA10

ATC

azithromycin; systemic

1.3

182.5

21510

91203

K59.09

ICD-10 Finland

Constipation, unspecified

2.2

182.1

1987

4733

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

181.4

4479

13997

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.0

181.3

1014

1726

M48.0

ICD-10 Finland

Spinal stenosis

1.8

180.8

3423

9914

R96

ICPC

Asthma

1.9

179.7

2935

8110

A02BC01

ATC

omeprazole; systemic

1.5

179.6

8977

32929

U02

ICPC

Urinary frequency/urgency

1.7

179.4

4382

13651

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

179.2

3456

10065

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

179.1

3934

11901

N05BA01

ATC

diazepam; systemic, rectal

1.7

178.8

3974

12063

A98

ICPC

Health maint/preventive medicine

1.6

178.5

41353

195933

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

178.2

6616

22819

SPAT1229

SPAT

Assessment of need for aid

2.1

177.9

2063

5035

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

177.5

7867

28169

WZC30

NOMESCO Finland

Teaching

1.6

177.3

5085

16509

ZXA05

NOMESCO Finland

Left side

1.5

176.6

7564

26889

P20

ICPC

Memory disturbance

1.7

176.4

3786

11377

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

175.7

4149

12803

A10BA02

ATC

metformin; oral

1.4

175.7

9121

33679

N17

ICPC

Vertigo/dizziness

1.7

174.9

3849

11647

L12

ICPC

Hand/finger symptom/complaint

1.6

174.6

5703

19098

R60.0

ICD-10 Finland

Localized oedema

1.7

174.2

3786

11415

D11

ICPC

Diarrhoea

1.7

174.2

4061

12487

G04CA02

ATC

tamsulosin; oral

1.5

172.6

7891

28411

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

172.6

3819

11572

P76

ICPC

Depressive disorder

2.0

172.5

2198

5562

XKD00

NOMESCO Finland

Uroflowmetry

1.6

172.5

4807

15487

C08CA01

ATC

amlodipine; oral

1.4

172.5

12294

48015

A10AB04

ATC

insulin lispro; parenteral

3.2

172.0

875

1403

X58

ICD-10 Finland

Exposure to other specified factors

1.6

171.9

5107

16716

J01FA06

ATC

roxithromycin; oral

1.4

171.5

13499

53582

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

171.3

2779

7658

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

171.1

7867

28351

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.5

170.2

1335

2738

ZYC01

NOMESCO Finland

Remote contact by phone

2.1

170.2

1879

4495

H02

ICPC

Hearing complaint

1.7

170.0

4215

13174

N06AX26

ATC

vortioxetine; oral

1.9

169.8

2551

6849

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.5

169.7

6219

21365

N02BF02

ATC

pregabalin; oral

2.1

169.7

2008

4938

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

169.7

2915

8184

L15

ICPC

Knee symptom/complaint

1.5

169.4

8052

29202

N06AB03

ATC

fluoxetine; oral

1.7

169.4

3633

10909

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.3

168.8

1631

3687

N30.0

ICD-10 Finland

Acute cystitis

1.6

168.8

5342

17747

H02AB04

ATC

methylprednisolone; systemic

1.6

168.7

4356

13758

EBA00

NOMESCO Finland

Extraction of tooth

1.4

167.5

13296

52802

R52.9

ICD-10 Finland

Pain, unspecified

1.8

167.0

3205

9312

R52.2

ICD-10 Finland

Other chronic pain

2.8

166.6

1046

1906

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

165.6

6405

22253

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

165.6

3351

9891

A02BA02

ATC

ranitidine; systemic

1.5

165.4

5696

19290

N03AE01

ATC

clonazepam; systemic

2.3

165.2

1607

3643

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.9

165.2

622

802

Z50.1

ICD-10 Finland

Other physical therapy

2.4

165.2

1420

3044

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

164.1

10040

38132

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.9

164.0

947

1643

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.8

163.5

1046

1926

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.5

162.8

706

1014

R74

ICPC

Upper respiratory infection acute

1.4

162.8

12170

47813

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

162.5

1910

4684

N06AX12

ATC

bupropion; oral

1.9

162.5

2378

6325

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.8

162.3

3260

9599

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

162.0

2452

6597

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

161.7

6613

23239

M01AB05

ATC

diclofenac; systemic, rectal

1.3

161.4

24545

107179

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

160.6

14227

57396

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

160.5

2685

7469

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.4

160.4

1327

2793

UJF92

NOMESCO Finland

Capsular endoscopy

3.9

160.3

612

798

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

13.6

160.0

234

L13

ICPC

Hip symptom/complaint

1.5

160.0

5600

19022

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

159.9

7205

25818

H03AA01

ATC

levothyroxine sodium; systemic

1.5

159.8

6919

24595

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

159.5

2120

5446

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.1

159.5

1911

4721

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.9

158.0

2273

6008

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.5

157.8

508

573

AN1

Coronary angiography

1.8

157.2

2958

8538

R55

ICD-10 Finland

Syncope and collapse

1.7

156.9

3450

10422

ZXD05

NOMESCO Finland

Urgent procedure

1.4

156.8

10385

39932

R06AX27

ATC

desloratadine; oral

1.4

156.7

9980

38117

WX002

NOMESCO Finland

Sedation and analgesia

1.5

156.4

5675

19423

R21

ICPC

Throat symptom/complaint

1.5

156.1

7597

27623

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

154.6

3604

11063

SFA30

NOMESCO Finland

Three-surface restoration

1.3

154.1

14608

59444

A03

ICPC

Fever

1.5

153.8

6116

21343

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

153.7

7499

27269

Z00.6

ICD-10 Finland

Examination for normal comparison and control in clinical research programme

7.3

153.2

318

220

A10AB01

ATC

insulin (human); parenteral

2.7

152.9

1011

1896

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

151.7

4394

14265

H53.1

ICD-10 Finland

Subjective visual disturbances

2.0

151.6

2083

5415

R5110, ,

SPAT

1.9

151.2

2309

6228

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.9

151.1

2502

6933

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

151.1

3645

11291

R01AD58

ATC

fluticasone, combinations; nasal

1.4

150.8

8621

32274

Z2445

NOMESCO Finland

Psychologist

2.5

150.8

1151

2328

L16

ICPC

Ankle symptom/complaint

1.7

150.1

3811

11964

R20.2

ICD-10 Finland

Paraesthesia of skin

1.9

149.5

2161

5719

CS494

NOMESCO Finland

Other visual field testing

3.6

148.9

624

874

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.9

148.8

2325

6319

M79.7

ICD-10 Finland

Fibromyalgia

2.9

148.7

879

1546

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

148.6

3110

9258

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

148.4

6941

25015

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

148.4

2597

7324

R03BA05

ATC

fluticasone; inhalant

1.5

148.0

5860

20415

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

147.4

12431

49612

A10AE06

ATC

insulin degludec; parenteral

2.6

147.3

1021

1964

H04AA01

ATC

glucagon; nasal, parenteral

3.4

146.7

676

1014

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

146.6

3455

10631

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.6

146.0

454

496

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

145.9

4790

16011

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.4

145.8

12269

48931

A02BC04

ATC

rabeprazole; oral

1.8

145.8

2540

7152

J45.1

ICD-10 Finland

Nonallergic asthma

2.0

145.7

2052

5380

SPAT1262

SPAT

Handing over of treatment supplies

1.5

145.5

5178

17624

N06BA04

ATC

methylphenidate; oral

2.5

145.4

1163

2407

A46

ICD-10 Finland

Erysipelas

1.6

145.3

4617

15314

M54.2

ICD-10 Finland

Cervicalgia

1.8

144.9

2431

6762

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.1

144.6

1647

3986

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

144.3

3468

10725

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

143.7

3358

10305

Z3226

NOMESCO Finland

Physiotherapist

1.5

143.2

5542

19205

N05AX12

ATC

aripiprazole; systemic

2.4

142.1

1253

2716

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

142.1

3051

9145

J05AB01

ATC

aciclovir; systemic

1.4

141.8

6933

25179

A11

ICPC

Chest pain NOS

1.8

141.7

2443

6855

P06

ICPC

Sleep disturbance

1.6

141.6

4265

13963

TAB00

NOMESCO Finland

Lumbar puncture

2.4

141.3

1236

2669

R4110, ,

SPAT

1.6

141.3

3782

12026

E000001, ,

ATC

1.5

141.1

6490

23290

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

140.6

2363

6575

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

140.5

3950

12715

XG405

NOMESCO Finland

Education on PEF monitoring

5.4

140.4

376

354

N05BA12

ATC

alprazolam; oral

1.7

140.3

2849

8402

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.6

139.8

3893

12502

H29

ICPC

Ear symptom/complaint other

1.6

139.7

3645

11513

R01AD12

ATC

fluticasone furoate; nasal

1.4

139.6

10922

43009

N01

ICPC

Headache

1.6

139.5

3772

12023

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

139.5

1536

3666

H01

ICPC

Ear pain/earache

1.6

139.4

3845

12317

D07AC13

ATC

mometasone; topical

1.4

139.0

9599

37045

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.4

138.8

9657

37311

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

138.8

8874

33806

UDC00

NOMESCO Finland

Ear microscopy

1.9

138.6

2154

5841

M01AX17

ATC

nimesulide; oral

1.4

138.1

6988

25528

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

138.1

9638

37253

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

2.3

138.0

1273

2817

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

137.8

12087

48423

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.9

137.4

812

1428

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.4

137.1

1156

2454

C10AA07

ATC

rosuvastatin; oral

1.4

137.0

10541

41376

R35

ICD-10 Finland

Polyuria

1.9

136.9

1969

5198

C01CA24

ATC

epinephrine; parenteral

2.0

136.4

1792

4579

SPAT1360

SPAT

Extensive global examination

2.0

136.0

1912

5007

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

135.9

2303

6424

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

135.8

37170

174122

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

135.0

6825

24916

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.0

134.6

1719

4347

R29

ICPC

Respiratory symptom/complaint other

1.9

134.5

2021

5417

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

134.5

2539

7325

SPAT1260

SPAT

Consultation of another employee

1.5

134.4

5362

18678

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

134.1

6945

25467

R00.2

ICD-10 Finland

Palpitations

1.8

133.5

2344

6611

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

133.3

7846

29436

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

133.3

5302

18455

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

133.2

3497

11058

R31

ICD-10 Finland

Unspecified haematuria

1.7

132.9

3143

9669

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

132.3

1210

2667

B01AA03

ATC

warfarin; systemic

1.5

132.1

5764

20443

R03BB04

ATC

tiotropium bromide; inhalant

1.7

131.7

2907

8774

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

131.7

7485

27903

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.7

131.6

2793

8337

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.7

131.5

3157

9751

A10AC01

ATC

insulin (human); parenteral

1.8

130.6

2233

6244

T78.4

ICD-10 Finland

Allergy, unspecified

2.2

130.6

1293

2951

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.2

130.4

643

1010

M01AH01

ATC

celecoxib; oral

1.5

130.2

5178

18018

H25.8

ICD-10 Finland

Other senile cataract

1.7

129.5

2922

8872

P99

ICPC

Psychological disorders other

2.6

129.5

946

1870

C10AX09

ATC

ezetimibe; oral

1.5

129.4

4857

16693

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

129.2

1892

5025

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

129.0

3109

9611

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

128.7

4072

13469

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.6

128.7

954

1900

Z2446

NOMESCO Finland

Social worker

1.9

128.1

1924

5155

L29

ICPC

Musculoskeletal sympt/complt other

1.7

128.0

2611

7704

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

127.9

26324

117868

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.7

127.9

863

1636

R03BA08

ATC

ciclesonide; inhalant

1.8

127.8

2451

7101

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.1

127.6

1559

3876

A10BH01

ATC

sitagliptin; oral

1.8

127.3

2548

7477

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

127.2

2091

5773

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

126.4

4331

14586

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.1

126.1

656

1067

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.3

125.7

1218

2754

R03BA02

ATC

budesonide; inhalant

1.5

125.2

5669

20236

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

125.2

1583

3987

SPAT1312

SPAT

General health counselling

1.3

124.8

10648

42353

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.1

124.8

1376

3285

N05AX08

ATC

risperidone; systemic

1.7

124.6

2676

8012

SPAT1234

SPAT

Support of social functional capacity

2.1

124.0

1411

3411

C09AA05

ATC

ramipril; oral

1.4

124.0

7541

28409

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.9

123.7

739

1308

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.8

123.5

2134

5985

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

122.3

5913

21368

J01MA14

ATC

moxifloxacin; systemic

1.7

122.2

2569

7643

R5599

NOMESCO Finland

Other rehabilitation service

2.8

121.3

732

1303

G04BD12

ATC

mirabegron; oral

1.6

121.1

3123

9820

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

17.0

121.1

162

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

121.1

2715

8225

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

120.8

4414

15068

EB1VA, ,

NOMESCO Finland

1.4

120.6

5803

20945

D06

ICPC

Abdominal pain localized other

1.7

120.3

2682

8111

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

120.3

2071

5801

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

119.8

2736

8329

XA800

NOMESCO Finland

Neuropsychological investigation

2.2

119.7

1186

2707

F34.1

ICD-10 Finland

Dysthymia

2.4

119.7

1016

2163

H3600, E103,

ICD-10 Finland

5.8

119.7

300

263

A05

ICPC

Feeling ill

1.8

119.6

1981

5481

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.8

119.3

742

1344

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

119.2

3995

13378

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.4

119.2

535

788

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

118.8

1614

4173

SDA03

NOMESCO Finland

Periodontal treatment

1.3

118.7

14420

60177

UJD02

NOMESCO Finland

Gastroscopy

2.1

118.5

1282

3036

P74

ICPC

Anxiety disorder/anxiety state

2.1

118.4

1444

3586

R06AX22

ATC

ebastine; oral

1.5

118.2

5284

18797

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

117.7

6759

25184

SPAT1359

SPAT

Use of symptom diary

3.2

117.6

577

903

J01FA09

ATC

clarithromycin; systemic

1.3

117.2

10256

40880

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

116.8

2907

9053

ZXA10

NOMESCO Finland

Bilateral

1.5

116.8

5415

19396

R83

ICPC

Respiratory infection other

1.3

116.5

9111

35701

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

116.3

3654

12053

D02

ICPC

Abdominal pain epigastric

1.9

116.1

1773

4774

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

115.9

6935

26017

E66.8

ICD-10 Finland

Other obesity

2.0

115.8

1608

4189

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.8

115.6

699

1246

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

115.4

2041

5765

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.9

115.3

1825

4974

R06.5

ICD-10 Finland

Mouth breathing

1.7

114.9

2737

8425

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.3

114.6

387

456

N04BC05

ATC

pramipexole; oral

1.8

114.4

1974

5532

C01DA14

ATC

isosorbide mononitrate; oral

1.5

114.0

4644

16208

SPAT1043

SPAT

Audiometry

1.7

113.8

2579

7832

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.2

113.4

1108

2513

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

113.3

2639

8074

L11

ICPC

Wrist symptom/complaint

1.6

113.2

2843

8874

R06AE09

ATC

levocetirizine; oral

1.5

113.1

4432

15342

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

113.1

2761

8554

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.3

112.9

9486

37547

SFA00

NOMESCO Finland

Small restoration

1.5

112.7

4335

14947

S21

ICPC

Skin texture symptom/complaint

1.5

112.4

4668

16352

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.8

112.3

1903

5302

TQW80

NOMESCO Finland

Local dermatologic skincare

2.8

112.2

689

1239

J01CA08

ATC

pivmecillinam; oral

1.3

111.8

12562

51784

L02

ICPC

Back symptom/complaint

1.6

111.7

3243

10494

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

111.7

8995

35371

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

111.3

1783

4877

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

111.0

4135

14158

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.6

110.6

3268

10619

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

110.6

13420

55866

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

110.4

2258

6660

G43.9

ICD-10 Finland

Migraine, unspecified

1.9

110.3

1773

4855

M54.6

ICD-10 Finland

Pain in thoracic spine

1.7

110.1

2198

6438

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

110.1

3609

12015

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

109.9

3984

13561

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

109.8

1393

3511

S97

ICPC

Chronic ulcer skin

1.9

109.3

1683

4543

R4110

NOMESCO Finland

Physiotherapy

1.3

109.3

8842

34776

J45.8

ICD-10 Finland

Mixed asthma

2.5

109.0

810

1615

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.1

109.0

1229

2959

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

108.8

1703

4623

D07AD01

ATC

clobetasol; topical

1.5

108.6

4993

17838

M02AA07

ATC

piroxicam; topical

1.3

108.5

11180

45511

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.8

108.2

2134

6228

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

8.9

108.0

196

111

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.0

107.4

1393

3539

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

3.2

107.4

528

828

127

Kela drug reimbursment

Transplant complication

3.9

107.3

403

519

K03.66

ICD-10 Finland

Tooth plaque

1.7

107.2

2310

6915

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

106.5

4142

14306

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.2

106.5

1041

2362

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

106.1

2834

8981

SPAT1104

SPAT

Monitoring of emergency patient

1.8

105.9

1750

4835

L14

ICPC

Leg/thigh symptom/complaint

1.7

105.6

2346

7082

A10AA01, ,

ATC

2.7

105.5

677

1248

RF410, ,

NOMESCO Finland

5.4

105.3

280

262

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.8

105.2

1818

5095

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.0

105.0

585

993

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

104.8

8563

33699

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.8

104.7

2050

5968

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.1

104.5

539

872

C08CA13

ATC

lercanidipine; oral

1.5

104.4

3966

13627

K07.60

ICD-10 Finland

Snapping jaw

2.0

104.0

1437

3735

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

103.6

1200

2920

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.2

103.2

513

810

SPAT1255

SPAT

Intravenous administration of medicine

1.8

103.2

1830

5170

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

4.4

103.1

337

386

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.7

103.0

2289

6908

G04CA01

ATC

alfuzosin; oral

1.5

102.7

3752

12783

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

102.6

8789

34813

L20.0

ICD-10 Finland

Besnier prurigo

1.7

102.4

2311

7004

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.6

102.1

710

1368

M02AA10

ATC

ketoprofen; topical

1.5

102.0

4675

16677

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.5

101.9

758

1512

M01AX05

ATC

glucosamine; oral

1.4

101.8

4863

17483

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

101.8

11514

47381

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

142.3

101.6

141

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

101.6

2157

6428

M04AA01

ATC

allopurinol; systemic

1.5

101.1

3859

13269

L04AA06

ATC

mycophenolic acid; systemic

3.2

101.0

497

780

D19

ICPC

Teeth/gum symptom/complaint

1.3

100.9

10650

43414

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.8

100.7

613

1097

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.2

100.6

1064

2496

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.9

100.5

1570

4257

Z71.9

ICD-10 Finland

Counselling, unspecified

1.7

100.4

2408

7418

J05AB11

ATC

valaciclovir; oral

1.5

100.2

4344

15325

U04

ICPC

Incontinence urine

1.9

100.2

1477

3927

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.7

100.2

1996

5839

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

100.2

11791

48749

C03DA01

ATC

spironolactone; oral

1.5

100.2

3531

11934

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.1

100.0

1092

2595

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

99.7

2373

7296

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.4

99.4

832

1759

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

99.3

18460

80602

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.6

99.1

3122

10289

Z13.6

ICD-10 Finland

Special screening examination for cardiovascular disorders

9.5

99.0

173

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

2.2

98.7

1017

2360

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.4

98.6

859

1851

GD1AD

NOMESCO Finland

Thorax CT examination

1.8

98.4

1665

4633

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.2

98.3

1008

2334

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

98.2

1696

4750

H26.4

ICD-10 Finland

After-cataract

1.6

97.9

2601

8226

SPAT1053

SPAT

Memory test

1.5

97.9

3452

11666

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

97.7

3381

11379

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.9

97.5

1380

3617

N06AX22

ATC

agomelatine; oral

2.7

97.5

642

1201

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.3

97.2

891

1965

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.1

97.1

497

800

M01AH02

ATC

rofecoxib; oral

1.5

96.9

3380

11394

F29

ICPC

Eye symptom/complaint other

1.5

96.9

3140

10413

H36.01

ICD-10 Finland

Diabetic maculopathy

4.2

96.8

334

401

R33

ICD-10 Finland

Retention of urine

1.7

96.7

2333

7196

XCW10

NOMESCO Finland

Assessment of vision

4.0

96.3

356

453

R01AD11

ATC

triamcinolone; nasal

1.6

96.2

2377

7378

B01AF02

ATC

apixaban; oral

1.5

95.9

3568

12196

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.9

95.7

572

1013

207

Kela drug reimbursment

Chronic arrhythmias

1.5

95.6

4281

15190

R03BA01

ATC

beclometasone; inhalant

1.5

95.5

4045

14197

R12

ICD-10 Finland

Heartburn

1.6

95.5

2493

7849

R01AD01

ATC

beclometasone; nasal

1.4

95.3

4539

16295

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

94.8

1059

2540

Z2221

NOMESCO Finland

Medical doctor

1.3

94.7

8731

34887

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.9

94.6

352

450

L04AX01

ATC

azathioprine; systemic

2.1

94.6

1137

2806

R03AC03

ATC

terbutaline; inhalant

1.5

94.6

4100

14455

H02AB09

ATC

hydrocortisone; systemic

2.7

94.6

604

1111

H40.0

ICD-10 Finland

Glaucoma suspect

1.7

94.5

2071

6223

SPAT1325

SPAT

Vaccination

1.3

94.3

10324

42221

GD1AA, ,

SPAT

1.4

94.2

5416

20110

C09CA06

ATC

candesartan; oral

1.3

94.2

7473

29218

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.9

94.2

1331

3487

K22

ICPC

Risk factor cardiovascular disease

1.9

93.9

1449

3912

H91.9

ICD-10 Finland

Hearing loss, unspecified

1.9

93.9

1369

3626

A99

ICPC

Disease/condition unspecnature/site

1.5

93.9

3069

10195

R09

ICPC

Sinus symptom/complaint

1.6

93.8

2401

7520

C09CA01

ATC

losartan; oral

1.3

93.8

7620

29895

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

93.5

11364

47088

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.4

93.5

813

1750

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.4

93.4

759

1582

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.0

93.3

1294

3367

C07AB02

ATC

metoprolol; systemic

1.4

93.2

5895

22240

A08

ICPC

Swelling

1.9

93.1

1475

4017

N76.0

ICD-10 Finland

Acute vaginitis

1.7

93.1

1841

5372

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.7

93.1

1852

5414

A10BK03

ATC

empagliflozin; oral

1.6

93.0

2764

8981

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.1

92.7

482

784

G04CB01

ATC

finasteride; oral

1.5

92.7

3263

11018

C05AA08

ATC

fluocortolone; rectal, topical

1.5

92.5

3841

13423

A07AA02

ATC

nystatin; oral

1.9

92.3

1445

3920

Z04.0

ICD-10 Finland

Blood-alcohol and blood-drug test

48.7

92.1

SPAT1307

SPAT

Psychosocial counselling and guidance

1.7

91.8

1863

5478

K78

ICPC

Atrial fibrillation/flutter

1.7

91.6

1980

5927

L04AX03

ATC

methotrexate; systemic

1.6

91.3

2713

8814

L04

ICPC

Chest symptom/complaint

1.8

91.1

1792

5220

WX704

NOMESCO Finland

Intubation

1.6

91.0

2330

7296

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.5

90.8

702

1428

U01

ICPC

Dysuria/painful urination

1.7

90.6

2153

6612

HMAK, ,

NOMESCO Finland

1.5

90.6

3428

11752

U05

ICPC

Urination problems other

1.9

90.5

1395

3765

J01DA09

ATC

[U] cefadroxil

1.3

90.1

8637

34666

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

90.0

1121

2804

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

89.9

1989

5991

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.0

89.6

1116

2792

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

89.6

3092

10392

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

89.5

925

2149

U07

ICPC

Urine symptom/complaint other

1.6

89.4

2347

7395

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

21.5

89.4

111

S22.3

ICD-10 Finland

Fracture of rib

1.7

89.4

2127

6534

Z11

ICPC

Compliance/being ill problem

6.1

89.3

211

173

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.9

89.2

1436

3931

K29

ICPC

Cardiovascular sympt/complt other

2.0

89.1

1081

2677

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

89.0

12990

54964

Z29

ICPC

Social problem NOS

2.6

89.0

621

1199

A56.0

ICD-10 Finland

Chlamydial infection of lower genitourinary tract

2.9

89.0

516

898

H93.1

ICD-10 Finland

Tinnitus

1.7

88.9

1925

5763

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

2.8

88.9

548

988

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

88.9

3734

13074

M05BA04

ATC

alendronic acid; oral

1.7

88.6

2085

6387

XQ801

NOMESCO Finland

Intracutantest

16.3

88.5

120

N07CA01

ATC

betahistine; oral

1.7

88.5

1865

5542

K80

ICPC

Cardiac arrhythmia NOS

1.6

88.5

2290

7190

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.4

88.4

404

603

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

88.1

4850

17859

Z04.1

ICD-10 Finland

Examination and observation following transport accident

15.1

88.1

123

S04

ICPC

Lump/swelling localized

1.5

88.0

3338

11445

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.7

88.0

2106

6480

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.8

87.9

1454

4015

H91.1

ICD-10 Finland

Presbycusis

1.8

87.9

1701

4931

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

1.7

87.9

1834

5434

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.4

87.9

754

1613

W19

ICD-10 Finland

Unspecified fall

1.5

87.9

3019

10135

-50

ICPC

Medication/prescr/renewal

2.1

87.8

1016

2471

SPAT1211

SPAT

Application of soft bandage

1.6

87.3

2402

7657

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.8

87.3

1467

4072

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.9

87.0

1268

3357

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.2

86.9

861

1965

A10BK01

ATC

dapagliflozin; oral

1.7

86.8

2121

6560

ACC51

NOMESCO Finland

Release of median nerve

1.7

86.7

1987

6042

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.9

86.7

493

848

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

86.6

3128

10613

H3601, E103,

ICD-10 Finland

5.3

86.6

235

225

Y96.9

ICD-10 Finland

Unspecified type of accident

2.9

86.6

496

857

Z03.0

ICD-10 Finland

Observation for suspected tuberculosis

25.6

86.1

102

U29

ICPC

Urinary symptom/complaint other

2.3

86.1

804

1788

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

86.0

2128

6604

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.5

85.9

3795

13415

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.9

85.7

1302

3496

RF420, ,

NOMESCO Finland

4.1

85.7

308

383

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.8

85.3

1523

4309

H53.2

ICD-10 Finland

Diplopia

2.2

85.2

822

1854

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

85.2

7446

29471

XG466

NOMESCO Finland

Sleep oxymetry

2.3

84.8

755

1643

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.8

84.8

1448

4040

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

7.0

84.7

180

129

B01AF01

ATC

rivaroxaban; oral

1.5

84.6

3276

11279

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.7

84.5

575

1095

K29.7

ICD-10 Finland

Gastritis, unspecified

2.1

84.0

900

2122

K04.08

ICD-10 Finland

Other specified pulpit

1.6

83.7

2483

8058

114

Kela drug reimbursment

Glaucoma

1.6

83.7

2266

7193

SPAT1058

SPAT

PEF monitoring instruction

1.6

83.3

2040

6312

JN4AD

NOMESCO Finland

Body CT examination

1.5

83.3

3083

10513

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.1

83.2

978

2393

XA420

NOMESCO Finland

Extensive sleep examination

4.9

83.1

241

247

J34.2

ICD-10 Finland

Deviated nasal septum

1.8

83.0

1536

4393

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.6

82.9

2459

7980

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

82.8

7357

29173

-34

ICPC

Blood test

2.3

82.8

731

1585

SPAT1059

SPAT

Spirometry at the office

1.9

82.8

1247

3339

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

4.9

82.7

242

250

K04

ICPC

Palpitations/awareness of heart

1.8

82.7

1412

3939

N05AN01

ATC

lithium; oral

2.5

82.6

628

1267

H02AB07

ATC

prednisone; oral

1.4

82.5

3837

13693

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

82.4

3634

12836

G04BD08

ATC

solifenacin; oral

1.8

82.4

1561

4496

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.6

82.4

565

1081

J30.3

ICD-10 Finland

Other allergic rhinitis

2.1

82.1

992

2453

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.5

82.0

3294

11422

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

81.9

1573

4549

WX320

NOMESCO Finland

Spinalanesthesy

1.3

81.9

7365

29249

XJH00

NOMESCO Finland

Transanal ultrasonography

1.8

81.8

1589

4610

F61.0

ICD-10 Finland

Mixed personality disorders

3.1

81.7

425

692

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.0

81.5

1010

2522

SGA01

NOMESCO Finland

Emergency treatment

1.4

81.5

5355

20292

N39.3

ICD-10 Finland

Stress incontinence

1.7

81.2

1634

4790

IBZ06

NOMESCO Finland

Evaluation concerning developmental neuropsychiatry

7.4

81.1

166

113

N06AX03

ATC

mianserin; oral

1.9

81.1

1198

3186

-69

ICPC

Other reason for encounter NEC

2.1

81.0

946

2309

H57.1

ICD-10 Finland

Ocular pain

2.0

81.0

1078

2764

A63.0

ICD-10 Finland

Anogenital (venereal) warts

2.0

80.9

1035

2615

N06AB05

ATC

paroxetine; oral

1.8

80.7

1568

4550

-, ,

ICD-10 Finland

2.6

80.6

557

1070

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

80.5

6185

24005

-42

ICPC

Electrical tracing

3.8

80.3

317

425

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

2.0

80.3

1062

2716

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.8

80.2

1352

3756

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.6

80.1

582

1148

N03AF02

ATC

oxcarbazepine; oral

2.1

80.0

884

2111

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.5

80.0

2891

9806

F41.00

ICD-10 Finland

Moderate panic disorder

3.1

79.9

421

691

K07

ICPC

Swollen ankles/oedema

1.9

79.7

1152

3041

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.1

79.5

854

2016

Z25.1

ICD-10 Finland

Need for immunization against influenza

1.8

79.4

1448

4122

S01ED51

ATC

timolol, combinations; ophthalmic

1.6

79.4

1972

6123

S80.0

ICD-10 Finland

Contusion of knee

1.6

79.2

2266

7288

A06AC51

ATC

ispaghula, combinations; oral

1.9

79.1

1181

3152

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

4.1

78.9

281

347

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.6

78.8

2409

7870

L04AD02

ATC

tacrolimus; systemic

4.1

78.5

276

337

S76

ICPC

Skin infection other

1.8

78.2

1463

4197

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

78.2

6645

26161

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.4

78.1

650

1371

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

78.1

8108

32801

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

78.0

2517

8325

K92.1

ICD-10 Finland

Melaena

1.8

78.0

1468

4219

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.8

77.8

490

895

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.8

77.6

1375

3880

D07BC01

ATC

betamethasone and antiseptics; topical

1.5

77.6

3437

12146

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

77.3

2508

8306

M10.9

ICD-10 Finland

Gout, unspecified

1.6

77.2

1912

5931

WZC00, ,

SPAT

1.4

77.2

4696

17559

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

77.2

1497

4341

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

76.9

1597

4723

N05BE01

ATC

buspirone; oral

2.2

76.9

745

1684

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

76.8

1909

5927

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.8

76.6

1476

4271

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.4

76.5

5236

19952

J37.0

ICD-10 Finland

Chronic laryngitis

2.2

76.3

802

1876

D07XC01

ATC

betamethasone; topical

1.4

76.3

3530

12576

N07BB01

ATC

disulfiram; oral

1.9

76.2

1206

3282

R04

ICPC

Breathing problem other

2.0

76.1

1028

2649

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.0

76.1

922

2282

K10.3

ICD-10 Finland

Alveolitis of jaws

1.8

76.1

1380

3921

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

4.6

76.0

234

254

L05

ICPC

Flank/axilla symptom/complaint

1.7

75.9

1753

5338

K59.0

ICD-10 Finland

Constipation

1.7

75.9

1562

4608

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.2

75.8

796

1862

R1250

NOMESCO Finland

Evaluation of functional capability

2.4

75.5

625

1315

D12

ICPC

Constipation

2.0

75.2

968

2451

A10BH05

ATC

linagliptin; oral

1.8

75.2

1253

3467

D07AB08

ATC

desonide; topical

1.5

75.2

3221

11305

L86

ICPC

Back syndrome with radiating pain

1.7

75.1

1642

4927

R07.0

ICD-10 Finland

Pain in throat

1.6

75.0

2204

7132

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.5

75.0

2637

8888

GX1K5

NOMESCO Finland

Diffusion capacity

7.6

74.9

150

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

5.9

74.9

184

158

K08.80

ICD-10 Finland

Toothache NOS

1.5

74.8

2637

8892

S01

ICPC

Pain/tenderness of skin

1.8

74.7

1284

3588

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.7

74.7

1508

4424

J45

ICD-10 Finland

Asthma

1.5

74.3

3004

10423

WX892

NOMESCO Finland

Monitored bed care

1.6

74.2

2032

6464

N03AX11

ATC

topiramate; oral

2.4

74.2

598

1242

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

74.2

1253

3482

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.0

74.2

961

2439

SPAT1283

SPAT

Restricted health certificate

1.3

74.1

5724

22206

Z08

ICPC

Social welfare problem

3.4

74.0

340

510

Z12.5

ICD-10 Finland

Special screening examination for neoplasm of prostate

4.9

74.0

217

225

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.3

73.8

344

521

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

3.8

73.8

282

369

R60.9

ICD-10 Finland

Oedema, unspecified

1.7

73.6

1471

4303

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.7

73.3

1570

4683

M54.3

ICD-10 Finland

Sciatica

1.7

73.2

1568

4677

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

73.1

9961

41617

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.5

73.0

2329

7680

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

72.9

3720

13488

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.6

72.9

497

948

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.6

72.8

1931

6095

B81

ICPC

Anaemia vit B12/folate deficiency

2.0

72.6

913

2292

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.8

72.5

1212

3357

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.8

72.5

1324

3770

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.5

72.1

307

436

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.7

72.1

462

852

S01EE01

ATC

latanoprost; ophthalmic

1.7

72.0

1553

4641

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

5.1

71.8

201

199

R03AK08

ATC

formoterol and beclometasone; inhalant

1.9

71.7

1113

3009

F32.8

ICD-10 Finland

Other depressive episodes

2.8

71.6

443

801

S15

ICPC

Foreign body in skin

1.7

71.4

1696

5203

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.8

71.3

1257

3540

RD210, ,

NOMESCO Finland

2.8

71.1

432

773

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.7

71.0

1676

5133

P01BA02

ATC

hydroxychloroquine; oral

1.6

70.9

2070

6686

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.7

70.8

1585

4785

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

70.8

1326

3805

SPAT1285

SPAT

Provision of consultation response

1.8

70.7

1328

3813

UJH02

NOMESCO Finland

Anoscopy

1.9

70.7

986

2570

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

70.7

5554

21589

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.7

70.7

1559

4688

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

70.5

2765

9530

R06AX13

ATC

loratadine; oral

1.4

70.4

4452

16737

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

1.9

70.4

1013

2670

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.2

70.4

347

546

M54.1

ICD-10 Finland

Radiculopathy

1.9

70.4

1027

2720

N06AX05

ATC

trazodone; oral

2.4

70.3

595

1265

XW000

NOMESCO Finland

Bone marrow biopsy

2.0

70.3

964

2498

PA6AD

NOMESCO Finland

CT of neck arteries

2.0

70.3

930

2379

S10

ICPC

Boil/carbuncle

1.7

70.2

1658

5078

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.1

70.2

357

573

J46

ICD-10 Finland

Status asthmaticus

2.2

70.2

699

1599

R15

ICD-10 Finland

Faecal incontinence

2.4

70.2

599

1279

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.5

70.0

555

1144

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

4.7

70.0

214

231

XQ848

NOMESCO Finland

Dermatological photography

2.1

69.9

750

1770

P15

ICPC

Chronic alcohol abuse

2.0

69.8

848

2101

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.3

69.7

642

1419

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.7

69.5

1657

5088

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.5

69.5

2321

7732

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.1

69.2

780

1877

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

69.1

11645

49757

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

4.4

68.9

225

258

I95.1

ICD-10 Finland

Orthostatic hypotension

1.9

68.9

975

2555

TQW40

NOMESCO Finland

Remowal of suture of skin

1.6

68.8

1824

5755

WX722

NOMESCO Finland

PEEP

1.8

68.7

1131

3118

H3603, E103,

ICD-10 Finland

4.2

68.7

236

283

U71

ICPC

Cystitis/urinary infection other

1.6

68.6

1741

5432

F41.8

ICD-10 Finland

Other specified anxiety disorders

1.9

68.5

952

2479

L76

ICPC

Fracture: other

2.1

68.4

748

1779

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

24.2

68.3

D09

ICPC

Nausea

1.7

68.2

1364

3990

G04CB02

ATC

dutasteride; oral

1.6

68.2

2022

6555

WX872

NOMESCO Finland

Intensive care

1.8

68.0

1289

3712

H66.9

ICD-10 Finland

Otitis media, unspecified

1.6

67.9

2009

6510

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

67.8

2719

9412

LGA22

NOMESCO Finland

Hysteroscopic sterilisation

4.8

67.7

203

215

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.6

67.4

1660

5141

T90.5

ICD-10 Finland

Sequelae of intracranial injury

3.3

67.3

319

489

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

67.2

1606

4934

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

67.1

2716

9418

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.4

67.1

541

1124

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

67.1

1977

6398

JAH01

NOMESCO Finland

Laparoscopy

1.8

67.1

1103

3039

C10AC01

ATC

colestyramine; oral

2.2

67.0

646

1457

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

66.9

3521

12828

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.7

66.7

1440

4305

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

3.1

66.7

346

563

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.2

66.6

328

516

R04.0

ICD-10 Finland

Epistaxis

1.6

66.4

2021

6591

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

4.4

66.2

213

241

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

66.2

1948

6303

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

66.1

3982

14842

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.5

66.1

2307

7757

L09

ICPC

Arm symptom/complaint

1.7

66.1

1348

3965

P25

ICPC

Phase of life problem adult

1.8

66.0

1201

3415

L57.0

ICD-10 Finland

Actinic keratosis

1.5

65.9

2662

9226

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.4

65.9

526

1088

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.3

65.9

577

1247

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.7

65.8

1366

4038

K05.30

ICD-10 Finland

Periodontitis complex

1.4

65.8

4301

16245

N81.6

ICD-10 Finland

Rectocele

1.7

65.7

1297

3779

B02AA02

ATC

tranexamic acid; systemic

1.4

65.6

4004

14957

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.6

65.5

1691

5299

R4190

NOMESCO Finland

Nutritional therapy

1.8

65.4

1075

2962

D07AA02

ATC

hydrocortisone; topical

1.4

65.3

4371

16568

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

65.2

1811

5778

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.2

65.1

673

1564

A10BJ06

ATC

semaglutide; parenteral

1.7

65.1

1363

4039

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

3.0

65.1

358

604

H91.2

ICD-10 Finland

Sudden idiopathic hearing loss

2.3

64.9

600

1329

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

64.7

6836

27632

Z94.0

ICD-10 Finland

Kidney transplant status

3.7

64.6

262

359

-60

ICPC

Result test/procedure

1.7

64.6

1409

4223

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

1.9

64.5

1020

2775

R30.0

ICD-10 Finland

Dysuria

1.8

64.4

1188

3392

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.2

64.4

663

1538

J01CF05

ATC

flucloxacillin; systemic

1.5

64.4

2063

6806

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

64.3

6913

28003

R04.2

ICD-10 Finland

Haemoptysis

2.0

64.1

870

2246

R06.2

ICD-10 Finland

Wheezing

1.8

64.1

1186

3390

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.0

64.1

839

2138

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.8

64.0

1207

3470

SXC05

NOMESCO Finland

Other oral or dental procedure

1.6

63.9

1960

6403

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

1.8

63.8

1098

3070

R07

ICPC

Sneezing/nasal congestion

1.6

63.7

1966

6430

N05CD07

ATC

temazepam; oral

1.4

63.7

3205

11578

A11CC03

ATC

alfacalcidol; systemic

2.3

63.6

574

1258

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.9

63.5

956

2559

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.6

63.5

1774

5669

L50.8

ICD-10 Finland

Other urticaria

2.6

63.4

433

827

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.2

63.4

607

1365

R51.81

ICD-10 Finland

Facial pain NOS

2.3

63.4

567

1237

XQ820

NOMESCO Finland

Exposure to medicinal substance

13.3

63.4

M13.9

ICD-10 Finland

Arthritis, unspecified

1.5

63.4

2041

6741

K90

ICPC

Stroke/cerebrovascular accident

2.1

63.3

675

1589

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.4

63.3

2791

9840

SAA04

NOMESCO Finland

Special examination of mouth

1.7

63.3

1417

4278

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.8

63.2

1121

3163

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

63.1

2741

9634

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.1

63.1

703

1685

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.0

63.0

862

2232

B82

ICPC

Anaemia other/unspecified

2.1

62.8

727

1769

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.8

62.7

1085

3038

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.8

62.5

1009

2764

TK800

NOMESCO Finland

Hemodialysis

2.4

62.5

515

1082

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

62.4

2948

10527

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.0

62.3

802

2031

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

62.2

1923

6293

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.6

62.2

432

833

CKC12

NOMESCO Finland

Photocoagulation of retina

1.8

62.1

1040

2882

I50.0

ICD-10 Finland

Congestive heart failure

1.5

62.0

2096

6997

N06AA12

ATC

doxepin; systemic

1.7

62.0

1210

3514

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.0

61.9

346

590

E000006, ,

ATC

1.6

61.8

1723

5502

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.1

61.8

673

1598

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.5

61.6

2277

7748

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.6

61.5

1504

4647

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

5.6

61.5

157

141

L60.0

ICD-10 Finland

Ingrowing nail

1.7

61.5

1332

3985

N05AA02

ATC

levomepromazine; systemic

1.8

61.4

1030

2857

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

4.6

61.3

192

212

RF120, ,

NOMESCO Finland

3.6

61.3

252

349

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.6

61.3

1514

4690

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.3

61.3

4366

16699

F43.00

ICD-10 Finland

Acute stress reaction mild

2.2

61.3

638

1487

G54.0

ICD-10 Finland

Brachial plexus disorders

2.1

61.3

657

1550

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.5

61.2

2213

7496

R51

ICD-10 Finland

Headache

1.6

61.1

1619

5106

SPAT1167

SPAT

Insertion of urinary catheter

2.0

61.0

745

1850

N27

ICPC

Fear of neurological disease other

2.8

60.8

377

683

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.8

60.7

1170

3386

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.5

60.6

2649

9320

S22

ICPC

Nail symptom/complaint

1.6

60.6

1852

6043

F03

ICPC

Eye discharge

1.6

60.5

1898

6230

PLAK1, ,

NOMESCO Finland

3.5

60.5

257

365

VALMI, ,

NOMESCO Finland

1.3

60.3

7920

32837

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.0

60.2

755

1894

H92.0

ICD-10 Finland

Otalgia

1.6

60.2

1808

5876

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.9

60.2

863

2272

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.4

60.0

3212

11727

A01AB09

ATC

miconazole; local oral

1.5

60.0

2217

7542

D02AE01

ATC

carbamide; topical

1.6

60.0

1629

5168

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.3

60.0

549

1211

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.3

59.7

536

1172

M01AB55

ATC

diclofenac, combinations; oral

1.6

59.7

1596

5045

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.1

59.4

701

1718

A97

ICPC

No disease

1.3

59.4

6357

25712

S52.5

ICD-10 Finland

Fracture of lower end of radius

1.4

59.3

2665

9427

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

3.8

59.2

227

298

N05BA06

ATC

lorazepam; systemic, sublingual

1.7

59.2

1337

4045

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.4

59.2

493

1041

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.6

59.1

1422

4376

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

59.0

2641

9333

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

2.7

59.0

392

738

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

58.9

6711

27352

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.5

58.8

1907

6307

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.6

58.8

1648

5269

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.3

58.8

517

1120

NH1AD

NOMESCO Finland

Ankle and foot CT

2.2

58.8

601

1391

D03

ICPC

Heartburn

1.8

58.7

983

2725

L29.9

ICD-10 Finland

Pruritus, unspecified

2.0

58.6

709

1755

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

58.3

2529

8883

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.9

58.2

808

2103

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.7

58.2

372

686

M54.8

ICD-10 Finland

Other dorsalgia

1.7

58.2

1196

3526

K05

ICPC

Irregular heartbeat other

2.0

58.1

764

1951

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

57.9

2040

6870

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

57.8

3011

10939

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.4

57.8

2809

10080

D10

ICPC

Vomiting

1.6

57.7

1783

5833

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.5

57.6

1953

6522

K03.00

ICD-10 Finland

Approximal wear

1.5

57.6

2239

7696

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

57.6

1723

5595

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

3.3

57.5

271

414

OAB50

NOMESCO Finland

Delivery of care equipment and instruction on their use

3.1

57.3

294

475

A02BA04

ATC

nizatidine; systemic

1.5

57.3

1896

6297

E66.00

ICD-10 Finland

Metabolic syndrome

1.6

57.3

1437

4469

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

2.0

57.3

716

1794

B02.9

ICD-10 Finland

Zoster without complication

1.6

57.3

1708

5541

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.8

57.2

1074

3084

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.8

57.1

1079

3104

SPAT1251

SPAT

Organisation of medication

1.9

57.1

892

2418

N03AF01

ATC

carbamazepine; oral, rectal

1.7

57.0

1243

3725

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.3

57.0

506

1101

DFF59

NOMESCO Finland

Other assessment of balance

3.8

57.0

221

293

J02AC02

ATC

itraconazole; systemic

1.3

56.9

4906

19275

A03FA02

ATC

cisapride; oral, rectal

1.5

56.9

1872

6210

R1250, ,

SPAT

1.9

56.9

788

2050

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

5.9

56.8

139

119

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

56.8

5213

20659

A10AA02, ,

ATC

1.9

56.7

827

2190

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

56.7

3022

11023

C10AA04

ATC

fluvastatin; oral

1.5

56.6

2034

6877

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.3

56.6

518

1143

R52.0

ICD-10 Finland

Acute pain

1.9

56.6

872

2353

M35.7

ICD-10 Finland

Hypermobility syndrome

2.9

56.5

325

564

L84

ICPC

Back syndrome without radiat pain

1.7

56.4

1225

3667

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

3.3

56.4

261

394

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.0

56.4

748

1916

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.7

56.3

1203

3585

OAB50, ,

SPAT

1.5

56.2

2177

7477

K85

ICPC

Elevated blood pressure

1.3

56.2

4482

17419

H16.0

ICD-10 Finland

Corneal ulcer

1.6

56.1

1380

4270

R52.1

ICD-10 Finland

Chronic intractable pain

3.8

56.0

216

285

J01AA04

ATC

lymecycline; systemic

1.3

56.0

4004

15311

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

1.9

56.0

821

2178

R4180, ,

SPAT

3.2

56.0

273

427

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

55.9

2364

8261

R39.1

ICD-10 Finland

Other difficulties with micturition

1.9

55.9

814

2154

S82

ICPC

Naevus/mole

1.3

55.8

4205

16205

S01BC05

ATC

ketorolac; ophthalmic

1.8

55.8

951

2651

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.4

55.7

2547

9034

TKC20

NOMESCO Finland

Catheterisation of bladder

1.5

55.7

1792

5914

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.3

55.7

262

400

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

55.6

1660

5387

F32.1

ICD-10 Finland

Moderate depressive episode

1.5

55.5

1771

5835

FN1AD

NOMESCO Finland

CT of coronary arteries

2.5

55.5

415

832

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.4

55.4

447

930

SPAT1101

SPAT

Orthostatic test

1.8

55.2

968

2722

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.8

55.2

949

2653

N06BA12

ATC

lisdexamfetamine; oral

2.8

55.1

331

589

G04BD07

ATC

tolterodine; oral

1.7

55.1

1137

3356

S01.0

ICD-10 Finland

Open wound of scalp

1.5

55.0

2296

8004

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

4.0

54.9

199

250

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.7

54.9

1256

3814

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

4.4

54.8

176

199

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

2.5

54.8

413

831

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.9

54.8

854

2313

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.7

54.6

1063

3084

R10.0

ICD-10 Finland

Acute abdomen

1.8

54.5

876

2396

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.9

54.5

840

2267

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.4

54.4

3471

13041

R63.4

ICD-10 Finland

Abnormal weight loss

1.8

54.3

969

2740

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.4

54.1

2970

10884

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.7

54.0

1063

3094

T74.1

ICD-10 Finland

Physical abuse

2.3

53.9

492

1084

EBA10

NOMESCO Finland

Operative extraction of tooth

1.3

53.9

4402

17157

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.6

53.7

1499

4788

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.9

53.6

850

2315

D06BB04

ATC

podophyllotoxin; topical

1.6

53.4

1426

4504

E66.9

ICD-10 Finland

Obesity, unspecified

1.8

53.4

938

2639

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

2.4

53.4

442

931

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.9

53.4

203

265

L84

ICD-10 Finland

Corns and callosities

1.9

53.4

847

2307

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.8

53.4

889

2460

A23

ICPC

Risk factor NOS

1.4

53.4

2960

10866

R19.5

ICD-10 Finland

Other faecal abnormalities

2.5

53.3

394

785

L50.0

ICD-10 Finland

Allergic urticaria

2.0

53.3

643

1590

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.4

53.3

2777

10086

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.6

53.2

1567

5068

N06AG02

ATC

moclobemide; oral

1.8

53.2

994

2850

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.9

53.2

749

1960

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.4

53.1

2663

9606

R75

ICPC

Sinusitis acute/chronic

1.7

53.1

1239

3782

C09AA02

ATC

enalapril; systemic

1.3

53.0

5464

21964

A07EA06

ATC

budesonide; oral, local oral

1.8

53.0

935

2634

N05AF03

ATC

chlorprothixene; systemic

2.1

53.0

629

1546

S00.0

ICD-10 Finland

Superficial injury of scalp

2.1

52.9

614

1496

M05BX04

ATC

denosumab; parenteral

1.6

52.9

1325

4120

GX2C5

NOMESCO Finland

Short-lasting oximetry

6.0

52.8

126

105

R49.01

ICD-10 Finland

Functional dysphonia

2.0

52.7

680

1724

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.3

52.7

3747

14310

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.6

52.7

369

715

SPAT1172

SPAT

Guidance concerning hydration

2.2

52.7

512

1160

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.5

52.7

2207

7698

H60.3

ICD-10 Finland

Other infective otitis externa

2.1

52.6

590

1418

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.5

52.6

2104

7271

TQW99

NOMESCO Finland

Other minor procedure on skin

1.7

52.6

1210

3679

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.3

52.6

480

1058

L50.9

ICD-10 Finland

Urticaria, unspecified

1.8

52.5

999

2879

K05.31

ICD-10 Finland

Periodontitis pronounced

1.4

52.5

2941

10813

IBA03

NOMESCO Finland

Psychotherapy evaluation

3.3

52.5

250

385

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.9

52.5

738

1930

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.6

52.5

1258

3867

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.8

52.5

871

2408

H81.0

ICD-10 Finland

Ménière disease

2.2

52.4

502

1130

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.8

52.4

988

2840

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.1

52.4

619

1519

H60.8

ICD-10 Finland

Other otitis externa

1.9

52.3

822

2233

F40.1

ICD-10 Finland

Social phobias

2.0

52.2

714

1849

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.6

52.1

1578

5136

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.9

52.1

789

2116

Z06

ICPC

Unemployment problem

3.2

52.1

255

400

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.4

51.9

436

925

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

2.0

51.8

647

1621

S01EE05

ATC

tafluprost; ophthalmic

1.9

51.8

765

2035

E86

ICD-10 Finland

Volume depletion

2.0

51.7

647

1622

A10BB12

ATC

glimepiride; oral

1.5

51.6

1685

5579

A07EC01

ATC

sulfasalazine; oral, rectal

1.5

51.6

2151

7495

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

2.0

51.5

631

1570

Z03.4

ICD-10 Finland

Observation for suspected myocardial infarction

27.4

51.5

D01AE16

ATC

amorolfine; topical

1.4

51.5

3027

11219

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

1.9

51.5

820

2237

B18.2

ICD-10 Finland

Chronic viral hepatitis C

2.9

51.4

296

514

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

3.7

51.4

203

273

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.4

51.4

415

864

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.7

51.4

205

278

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

1.8

51.3

847

2337

ZX100

NOMESCO Finland

Oral

2.8

51.2

315

569

N89

ICPC

Migraine

1.7

51.1

990

2869

I49.5

ICD-10 Finland

Sick sinus syndrome

1.8

51.0

880

2462

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

2.0

50.9

640

1608

M03BX01

ATC

baclofen; systemic

2.3

50.9

456

997

S06

ICPC

Rash localized

1.6

50.9

1419

4531

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.3

50.8

475

1058

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.7

50.8

1062

3146

IHA10, ,

SPAT

2.0

50.8

648

1637

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.3

50.8

472

1049

W10

ICD-10 Finland

Fall on and from stairs and steps

1.6

50.7

1373

4352

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.1

50.7

579

1402

F06.7

ICD-10 Finland

Mild cognitive disorder

2.0

50.7

656

1666

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.9

50.7

788

2133

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.2

50.6

9817

42287

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.1

50.6

568

1366

R49.08

ICD-10 Finland

Other specified dysphonia

2.2

50.6

488

1102

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.4

50.6

2399

8565

J35.0

ICD-10 Finland

Chronic tonsillitis

1.6

50.5

1449

4658

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

2.0

50.3

688

1782

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

2.0

50.2

627

1571

A13

ICPC

Concern/fear medical treatment

2.3

50.1

453

994

A07EC02

ATC

mesalazine; oral, rectal

1.6

50.1

1449

4666

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.8

50.1

933

2673

P27

ICPC

Fear of mental disorder

2.6

50.0

355

693

Z08.1

ICD-10 Finland

Follow-up examination after radiotherapy for malignant neoplasm

117.2

50.0

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

1.9

50.0

721

1903

K50.0

ICD-10 Finland

Crohn disease of small intestine

2.5

49.9

371

742

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.9

49.8

744

1987

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.5

49.8

1936

6652

OAB93, ,

SPAT

1.5

49.7

2033

7055

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.5

49.7

1934

6646

R4120

NOMESCO Finland

Occupational therapy

1.5

49.6

1703

5700

C10AA03

ATC

pravastatin; oral

1.5

49.5

1646

5473

C02AC05

ATC

moxonidine; oral

1.7

49.4

1065

3181

Angiography of the heart and coronary arteries

1.6

49.3

1465

4747

XF600

NOMESCO Finland

Bloodpressure measurement

1.5

49.3

1667

5563

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.4

49.2

2326

8297

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.8

49.2

863

2427

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

2.0

49.2

587

1446

R06AX26

ATC

fexofenadine; oral

1.5

49.2

1823

6202

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

1.7

49.1

1107

3347

B03XA02

ATC

darbepoetin alfa; parenteral

2.2

49.1

475

1074

K04.09

ICD-10 Finland

Pulpit UNS

1.6

49.1

1295

4078

Z51.0

ICD-10 Finland

Radiotherapy session

2.9

49.1

279

481

TDA90

NOMESCO Finland

Removal wax from ear

2.8

49.1

300

540

L04AD01

ATC

ciclosporin; systemic

2.4

49.0

414

881

G43.3

ICD-10 Finland

Complicated migraine

2.4

49.0

414

881

C08CA02

ATC

felodipine; oral

1.4

48.9

2403

8634

K04.1

ICD-10 Finland

Necrosis of pulp

1.3

48.8

3297

12487

XQ899

NOMESCO Finland

Other assessment of skin

8.0

48.7

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.1

48.7

252

410

DJD20

NOMESCO Finland

Plastic repair of septum of nose

1.7

48.7

947

2748

I20.90

ICD-10 Finland

Angina pectoris, unspecified

1.8

48.6

811

2246

E000002, ,

ATC

1.4

48.5

3158

11894

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.2

48.4

499

1160

N80.9

ICD-10 Finland

Endometriosis, unspecified

2.3

48.0

444

985

R25.1

ICD-10 Finland

Tremor, unspecified

1.9

48.0

735

1980

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

47.8

1288

4077

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.8

47.8

768

2101

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.7

47.8

992

2933

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.2

47.7

465

1055

SPAT1081

SPAT

Cardiorespiratory global assessment

1.6

47.7

1223

3824

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

1.9

47.7

697

1848

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

2.0

47.6

639

1644

SBB10

NOMESCO Finland

Dental impressions

1.5

47.6

1952

6777

KHV, ,

NOMESCO Finland

4.3

47.5

160

189

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.6

47.5

1431

4652

A27

ICPC

Fear of other disease NOS

1.6

47.5

1264

3990

N80

ICPC

Head injury other

2.1

47.4

522

1246

J01MA01

ATC

ofloxacin; systemic

1.4

47.4

2144

7585

H53.4

ICD-10 Finland

Visual field defects

2.2

47.3

476

1095

EC1VA, ,

NOMESCO Finland

1.6

47.3

1258

3971

WX199

NOMESCO Finland

Other local analgesia

1.8

47.2

788

2182

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.7

47.2

993

2946

J20

ICD-10 Finland

Acute bronchitis

1.4

47.2

2956

11062

N19

ICD-10 Finland

Unspecified kidney failure

1.7

47.2

909

2630

N81.1

ICD-10 Finland

Cystocele

1.6

47.2

1250

3941

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.1

47.1

530

1276

R32

ICD-10 Finland

Unspecified urinary incontinence

2.0

47.1

586

1467

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.8

47.1

862

2457

J01FA15

ATC

telithromycin; oral

1.4

47.0

2583

9460

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.0

47.0

562

1386

B80

ICPC

Iron deficiency anaemia

2.0

47.0

628

1614

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

1.8

46.9

881

2530

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.4

46.9

376

781

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

5.0

46.8

133

134

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.6

46.8

1357

4372

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.8

46.7

831

2348

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

3.8

46.7

183

245

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.6

46.7

1392

4515

M89.0

ICD-10 Finland

Algoneurodystrophy

3.6

46.6

194

272

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.1

46.5

503

1192

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.0

46.5

615

1574

S70.0

ICD-10 Finland

Contusion of hip

1.7

46.5

1011

3027

Z72.2

ICD-10 Finland

Drug use

4.4

46.5

151

173

K28

ICPC

Limited function/disability (K)

2.1

46.4

498

1177

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.7

46.4

1095

3353

I20.00

ICD-10 Finland

Unstable angina

1.9

46.3

703

1888

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.5

46.3

1627

5473

I25.2

ICD-10 Finland

Old myocardial infarction

1.5

46.3

1764

6036

XA400

NOMESCO Finland

EEG

4.8

46.2

137

144

D18

ICPC

Change in faeces/bowel movements

2.0

46.2

625

1613

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.0

46.1

562

1396

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

3.2

46.1

222

345

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.3

46.1

215

327

K05.18

ICD-10 Finland

Chronic gingivitis

1.4

45.9

2163

7710

WX702

NOMESCO Finland

Supraglottic ventilation device

1.5

45.9

1471

4850

WX882

NOMESCO Finland

High dependency care

1.9

45.9

659

1737

GX1E5, ,

SPAT

2.8

45.8

277

496

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.8

45.7

837

2386

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

7.3

45.6

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.6

45.6

1164

3637

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.0

45.5

569

1427

S19

ICPC

Skin injury other

1.7

45.5

997

2992

S08

ICPC

Skin colour change

1.6

45.5

1327

4282

EMB10

NOMESCO Finland

Tonsillectomy

1.5

45.5

1631

5510

S01EC04

ATC

brinzolamide; ophthalmic

1.8

45.5

835

2382

P18

ICPC

Medication abuse

3.8

45.4

177

236

F05

ICPC

Visual disturbance other

1.8

45.4

776

2166

J01MA06

ATC

norfloxacin; oral

1.3

45.2

3424

13187

L74

ICPC

Fracture: hand/foot bone

2.0

45.1

544

1346

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

2.1

45.0

522

1272

IHZ05, ,

SPAT

1.6

45.0

1326

4288

N99.3

ICD-10 Finland

Prolapse of vaginal vault after hysterectomy

2.7

45.0

297

558

N29

ICPC

Neurological sympt/complt other

2.2

44.9

436

988

Z02.4

ICD-10 Finland

Examination for driving licence

1.2

44.9

8112

34642

NG2AA

NOMESCO Finland

Patella X-ray examination

1.9

44.9

614

1591

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.8

44.9

845

2429

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.7

44.9

928

2741

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.1

44.9

514

1247

I20.09

ICD-10 Finland

Unstable angina

1.6

44.8

1373

4481

JN4BD

NOMESCO Finland

Extensive body CT

1.4

44.8

2577

9511

CL2S4, ,

SPAT

2.1

44.8

522

1275

205

Kela drug reimbursment

Chronic hypertension

1.2

44.8

7616

32330

J01FA01

ATC

erythromycin; systemic

1.3

44.7

4190

16616

NF3AA

NOMESCO Finland

Femur X-ray examination

2.1

44.7

519

1266

A12AA04

ATC

calcium carbonate; oral

2.5

44.6

350

719

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.1

44.6

502

1209

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.2

44.6

427

962

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.6

44.6

1242

3964

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

4.1

44.6

157

193

TND32

NOMESCO Finland

Custom moulded splint, wrist or hand

2.7

44.5

291

544

T82

ICPC

Obesity

1.6

44.5

1101

3413

G50.1

ICD-10 Finland

Atypical facial pain

2.4

44.4

375

798

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.5

44.4

1528

5116

IGY02, ,

SPAT

2.2

44.4

428

967

WX400

NOMESCO Finland

Inhalation anesthesy

1.7

44.4

1032

3147

M54

ICD-10 Finland

Dorsalgia

1.3

44.3

3848

15104

A92

ICPC

Allergy/allergic reaction NOS

1.8

44.3

800

2271

NH1FA

NOMESCO Finland

Weight-bearing X-ray of ankle

2.9

44.3

257

449

K08.3

ICD-10 Finland

Retained dental root

1.4

44.3

2126

7604

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.8

44.1

768

2156

F32

ICD-10 Finland

Depressive episode

1.5

44.1

1503

5023

M77.4

ICD-10 Finland

Metatarsalgia

1.5

44.0

1584

5355

M77.1

ICD-10 Finland

Lateral epicondylitis

1.4

44.0

2295

8329

A60.0

ICD-10 Finland

Herpesviral infection of genitalia and urogenital tract

2.1

44.0

483

1152

S20.2

ICD-10 Finland

Contusion of thorax

1.5

43.9

1462

4861

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

1.7

43.9

915

2709

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.5

43.9

1510

5057

EB4VA, ,

NOMESCO Finland

1.3

43.8

5464

22431

Z51.6

ICD-10 Finland

Desensitization to allergens

2.6

43.8

295

561

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

43.6

1278

4129

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

2.4

43.5

361

762

SPAT1210

SPAT

Application of cast or individual aid

1.7

43.5

956

2871

R08

ICPC

Nose symptom/complaint other

1.7

43.5

902

2666

K03.80

ICD-10 Finland

Irradiated enamel

1.5

43.5

1470

4904

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.3

43.4

3280

12623

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.5

43.4

1504

5043

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.0

43.4

156

195

P19

ICPC

Drug abuse

2.9

43.4

256

452

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.0

43.3

516

1271

R03AC13

ATC

formoterol; inhalant

1.6

43.3

1187

3774

RF210, ,

NOMESCO Finland

1.9

43.3

633

1679

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.5

43.2

319

636

G01AA10

ATC

clindamycin; vaginal

1.3

43.1

3418

13245

F93.89

ICD-10 Finland

Other childhood emotional disorders

3.7

43.1

173

236

Z03

ICPC

Housing/neighbourhood problem

3.8

43.1

165

217

L99

ICPC

Musculoskeletal disease other

2.0

43.1

536

1342

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.4

43.1

362

769

K99

ICPC

Cardiovascular disease other

1.9

43.1

594

1544

N06AA10

ATC

nortriptyline; systemic

2.1

43.0

458

1079

R2110

NOMESCO Finland

Giving the first information

1.5

43.0

1701

5863

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.8

43.0

728

2026

F33.8

ICD-10 Finland

Other recurrent depressive disorders

3.1

43.0

223

364

P02

ICPC

Acute stress reaction

1.5

42.9

1544

5219

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.5

42.9

1784

6211

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

2.5

42.8

312

618

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

2.3

42.8

375

812

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

1.7

42.8

922

2754

XJC10

NOMESCO Finland

Oesophageal pH monitoring

4.8

42.7

127

134

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.7

42.7

285

539

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.6

42.7

1204

3854

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

3.2

42.6

209

329

Y94.0

ICD-10 Finland

Accident at home

2.2

42.6

432

998

A10BJ02

ATC

liraglutide; parenteral

1.9

42.6

664

1800

SPAT1236

SPAT

Informing family of child’s disability

2.2

42.6

442

1031

SGC10

NOMESCO Finland

Pulp capping

1.4

42.5

2641

9867

K13.78

ICD-10 Finland

Other change in the oral mucosa

1.9

42.5

608

1601

Z31.5

ICD-10 Finland

Genetic counselling

1.5

42.5

1406

4669

SPAT1273

SPAT

Structured assessment of psychoactive substance / tobacco use

1.7

42.4

959

2903

S01EA05

ATC

brimonidine; ophthalmic

2.0

42.4

555

1416

H81

ICPC

Excessive ear wax

1.3

42.4

5044

20590

IHZ05

NOMESCO Finland

Therapeutic conversation

5.0

42.3

120

121

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.2

42.2

438

1021

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.5

42.2

1464

4910

XQ902

NOMESCO Finland

Other photography

2.9

42.2

246

431

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.0

42.2

503

1240

A04AA01

ATC

ondansetron; systemic, rectal

1.4

42.1

2057

7378

TFP20

NOMESCO Finland

Cardiodefibrillation

1.5

42.1

1735

6028

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.4

42.1

2005

7161

S09

ICPC

Infected finger/toe

1.8

42.0

787

2259

M65.3

ICD-10 Finland

Trigger finger

1.6

42.0

1122

3545

J04.0

ICD-10 Finland

Acute laryngitis

1.7

42.0

980

2992

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

42.0

5095

20845

C61

ICD-10 Finland

Malignant neoplasm of prostate

1.4

42.0

2563

9549

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.7

41.9

945

2858

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

2.7

41.9

265

487

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.3

41.8

391

872

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

1.9

41.8

617

1642

JN3AE, ,

SPAT

1.6

41.7

1051

3273

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.3

41.7

378

832

ZYC05, ,

SPAT

1.7

41.6

969

2956

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.5

41.6

1429

4784

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.8

41.5

760

2167

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.6

41.5

1005

3098

R06.4

ICD-10 Finland

Hyperventilation

2.4

41.5

340

714

ZX112

NOMESCO Finland

Subcutaneous

2.1

41.5

451

1072

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

1.9

41.4

599

1584

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

2.8

41.4

248

442

D82

ICPC

Teeth/gum disease

1.2

41.4

12959

57997

R10.2

ICD-10 Finland

Pelvic and perineal pain

1.9

41.3

593

1563

-59

ICPC

Other therap proced/minor surg NEC

1.9

41.3

593

1564

TGC00

NOMESCO Finland

Bronchial lavation

2.0

41.2

553

1424

Z30.2

ICD-10 Finland

Sterilization

1.4

41.2

2570

9607

C07AG02

ATC

carvedilol; oral

1.5

41.2

1392

4644

N28

ICPC

Limited function/disability (N)

2.3

41.1

369

808

CS2P4

NOMESCO Finland

Optic nerve head imaging

3.7

41.1

167

230

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

2.6

41.1

294

577

L01BA01

ATC

methotrexate; systemic

1.7

41.1

823

2409

G04BD04

ATC

oxybutynin; oral, transdermal

1.6

41.0

1231

3998

R81

ICPC

Pneumonia

1.7

41.0

937

2844

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

2.7

41.0

261

481

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.3

40.9

382

852

XF602

NOMESCO Finland

Bloodpressure monitoring

2.7

40.8

257

471

J01DC02

ATC

cefuroxime; systemic

1.5

40.8

1396

4669

L18

ICPC

Muscle pain

1.6

40.8

1113

3535

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.2

40.8

411

947

D01BA02

ATC

terbinafine; oral

1.2

40.8

7863

33748

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

1.8

40.7

724

2046

I49.1

ICD-10 Finland

Atrial premature depolarization

1.7

40.7

839

2476

A41.9

ICD-10 Finland

Sepsis, unspecified

1.7

40.7

863

2568

L50.3

ICD-10 Finland

Dermatographic urticaria

2.2

40.6

407

936

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

1.8

40.5

662

1822

ZX114

NOMESCO Finland

Intramuscular

2.5

40.5

313

639

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

1.8

40.4

677

1878

EKA10

NOMESCO Finland

iopsy of buccal mucosa

2.0

40.4

505

1267

ZA1.0

ICD-10 Finland

Shoulder region

1.9

40.4

573

1505

M75.8

ICD-10 Finland

Other shoulder lesions

1.6

40.4

964

2961

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

3.8

40.3

153

200

R41.0

ICD-10 Finland

Disorientation, unspecified

1.7

40.3

769

2220

A10AB06

ATC

insulin glulisine; parenteral

3.0

40.3

220

371

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

1.8

40.3

656

1804

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

3.3

40.2

189

289

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.3

40.2

361

791

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

2.0

40.2

485

1201

160

Kela drug reimbursment

exenatide

2.2

40.2

404

930

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.6

40.2

1115

3556

S01GX08

ATC

ketotifen; ophthalmic

1.6

40.1

1195

3875

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.3

40.1

2780

10563

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.4

40.0

1733

6079

N18.8

ICD-10 Finland

Other chronic renal failure

1.9

40.0

549

1425

AN2

Balloon angioplasty, including several vessels

1.9

39.9

583

1546

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.4

39.9

2579

9693

XKC03

NOMESCO Finland

Water cystometry

1.9

39.8

594

1587

L20

ICPC

Joint symptom/complaint NOS

1.7

39.8

932

2848

F41.01

ICD-10 Finland

Severe panic disorder

3.7

39.8

158

214

B05DA

ATC

Isotonic solutions

3.6

39.8

165

231

H65.2

ICD-10 Finland

Chronic serous otitis media

2.4

39.7

313

645

TNX39

NOMESCO Finland

Other orthopedic bandage, unspecified region

2.3

39.7

347

751

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.6

39.6

1204

3922

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

3.5

39.6

172

249

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.5

39.6

1234

4043

C08DA01

ATC

verapamil; systemic

1.6

39.6

982

3046

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

1.9

39.5

573

1516

XCD20

NOMESCO Finland

Photoangiography of eye

2.3

39.5

370

826

S02

ICPC

Pruritus

1.6

39.5

950

2923

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3020682) Albumin/Creatinine [Ratio] in Urine

13402

48370

1.55

322.53

4.5

3.9

10.16

8.02

mg/mmol

3.86

8807

29568

(3012516) Albumin [Mass/volume] in Urine

13167

47357

1.55

321.51

3.8

3.2

54.28

49.07

mg/l

1.35

8811

29859

(3037522) Nuclear Ab [Titer] in Serum

6662

20258

1.76

309.87

1.4

1.3

525.19

504.89

titre

0.33

1357

3745

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

5136

14401

1.89

309.10

4.8

4.2

31.99

31.76

0.70

3614

9631

(3048689) Calprotectin [Mass/mass] in Stool

6388

19200

1.78

308.86

2.6

129.42

135.86

ug/g

0.67

5143

15431

(3036481) Cortisol [Moles/volume] in Serum or Plasma

4627

12526

1.95

308.41

2.2

2.3

376.33

387.48

nmol/l

2.67

4273

11779

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

7621

23248

1.77

307.65

2.0

1.7

—

(3009261) Glucose [Presence] in Urine by Test strip

22663

91311

1.49

307.65

4.1

3.2

0.09

0.19

estimate

0.43

4420

18762

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

39484

174148

2.02

307.65

18.1

11.9

23.21

25.60

mg/l

34.58

33423

137976

(3031040) Bacteria [#/volume] in Urine by Automated count

27448

107176

1.71

307.65

5.0

3.8

1231.66

1466.97

e6/l

0.29

300

2167

(40758558) Short blood count panel - Blood

13071

46193

1.59

307.65

7.0

5.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

21540

72728

1.92

307.65

8.1

5.9

1.21

mmol/l

1.25

19085

60261

(3021960) Folate [Moles/volume] in Serum or Plasma

12190

39878

1.73

307.65

1.7

1.6

19.71

19.63

nmol/l

0.24

10630

34037

(3022096) Basophils/Leukocytes in Blood

20756

73826

1.75

307.65

7.3

5.6

0.68

0.67

2.60

19547

69027

(3019198) Lymphocytes [#/volume] in Blood

23148

82467

1.83

307.65

7.1

5.4

1.92

1.93

e9/l

0.26

20792

71053

(3018010) Neutrophils/Leukocytes in Blood

21056

74710

1.77

307.65

7.1

5.4

57.11

57.31

1.52

20147

71544

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6892

20837

1.78

307.65

2.9

2.3

22.70

23.31

2.66

6447

19189

(3035350) Ketones [Presence] in Urine by Test strip

22568

90520

1.50

307.65

4.1

3.2

4.82

3.10

estimate

0.67

4666

19625

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

18847

64586

1.79

307.65

2.2

1.9

96.62

94.89

pmol/l

4.80

10507

34021

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

16245

56270

1.70

307.65

4.0

3.2

93.41

57.56

ng/l

0.58

10982

35974

(3007164) IgA [Mass/volume] in Serum or Plasma

9617

30913

1.71

307.65

1.5

1.4

2.38

g/l

0.12

6128

20064

(3013512) EKG study

14325

45485

1.84

307.65

3.7

3.2

0.79

0.72

0.43

102

(3023103) Potassium [Moles/volume] in Serum or Plasma

39670

174178

2.09

307.65

20.8

14.1

3.97

3.96

mmol/l

12.16

38938

169481

(3020564) Creatinine [Moles/volume] in Serum or Plasma

41118

188096

1.98

307.65

22.5

15.3

78.90

76.46

umol/l

34.40

40676

185560

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7451

22735

1.77

307.65

2.8

2.2

2.34

2.33

g/l

1.58

6950

20726

(3013115) Eosinophils [#/volume] in Blood

23413

82673

1.86

307.65

7.3

5.5

0.19

e9/l

0.39

20849

70643

(3013826) Glucose [Moles/volume] in Serum or Plasma

25186

92485

1.82

307.65

5.7

4.4

6.71

6.62

mmol/l

7.54

23860

86334

(3022948) Iron [Moles/volume] in Serum or Plasma

8020

24357

1.79

307.65

2.8

2.2

13.22

13.49

umol/l

2.12

7530

22516

(3013650) Neutrophils [#/volume] in Blood by Automated count

24787

91783

1.78

307.65

10.3

8.6

4.12

4.20

e9/l

4.84

21938

77082

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

37321

164760

1.75

307.65

16.6

12.2

83.98

84.38

ml/min/173m2

2.81

34790

148296

(3024561) Albumin [Mass/volume] in Serum or Plasma

19201

67826

1.72

307.65

5.6

4.5

35.93

35.78

g/l

2.69

18127

63268

(3006315) Basophils [#/volume] in Blood

22751

80016

1.85

307.65

7.1

5.4

0.04

e9/l

0.73

20023

66727

(3037467) Urinalysis macro (dipstick) panel - Urine

28645

113448

1.72

307.65

4.9

3.7

1.54

2.48

1.37

235

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

30728

119240

1.90

307.65

4.7

3.5

11.45

11.13

mm/h

3.32

29039

111217

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

12101

37945

1.82

307.65

2.5

2.1

2.81

2.77

mg/l

0.90

10596

32412

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

31713

123395

1.95

307.65

8.9

6.9

78.56

78.99

u/l

0.71

30358

116391

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

15030

54520

1.57

307.65

3.6

2.8

34.49

34.15

u/l

0.10

14279

51339

(3023368) Bacteria identified in Blood by Culture

12105

42103

1.60

307.65

4.6

4.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3936

9452

2.19

307.65

2.4

2.0

7.71

8.68

ug/l

1.20

3450

8327

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

10835

35776

1.68

307.65

1.4

1.3

1.83

1.75

u/ml

0.22

2948

10466

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

19862

76843

1.52

307.65

3.0

2.6

—

estimate

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

36783

158088

1.86

307.65

5.6

4.4

1.86

1.89

mu/l

3.37

34569

146490

(3017732) Neutrophils [#/volume] in Blood

6022

16918

1.90

307.65

3.3

2.7

4.61

4.52

e9/l

0.23

5246

14982

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

31729

130090

1.73

307.65

4.5

3.8

14.73

14.64

pmol/l

7.75

29551

119081

(40768797) Stomach Pathology biopsy report

6339

17566

1.94

307.65

1.3

1.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

22628

80045

1.83

307.65

6.9

5.9

11.40

12.11

umol/l

10.57

21601

75929

(3009508) Creatinine [Moles/volume] in Urine

14780

52246

1.62

307.65

3.8

3.1

7.85

8.08

mmol/l

5.81

12786

44259

(3001122) Ferritin [Mass/volume] in Serum or Plasma

21193

80935

1.58

307.65

3.4

2.7

118.21

120.77

ug/l

0.64

19970

75877

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

36912

163831

1.68

307.65

5.2

4.2

5.95

5.81

mmol/l

68.89

34399

151149

(3002030) Lymphocytes/Leukocytes in Blood

21232

77175

1.71

307.65

7.3

5.5

28.00

27.96

0.17

20248

72969

(3001604) Monocytes [#/volume] in Blood

22680

79885

1.84

307.65

7.1

5.4

0.58

0.59

e9/l

1.12

19958

66669

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

8573

27605

1.69

307.65

4.1

3.3

532.85

603.34

ng/l

0.23

6398

21053

(3019550) Sodium [Moles/volume] in Serum or Plasma

39604

173661

2.09

307.65

20.6

14.0

139.61

139.69

mmol/l

7.42

38943

169353

(3019225) pH of Specimen

4333

10000

2.30

307.65

4.5

3.4

7.36

7.34

5.58

3190

7050

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

12561

38940

1.85

307.65

3.4

2.8

1470.79

1458.35

ng/l

0.09

10748

33037

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

36204

160667

1.63

307.65

6.6

5.1

39.43

38.25

mmol/mol

93.93

34307

150846

(3019309) Folate [Moles/volume] in Red Blood Cells

7409

22075

1.82

307.65

1.8

1143.24

1203.23

nmol/l

5.72

5722

16639

(3021601) Nitrite [Presence] in Urine by Test strip

22327

89469

1.49

307.65

4.1

3.2

0.00

estimate

2.99

4589

19423

(3006504) Eosinophils/Leukocytes in Blood

20784

73738

1.76

307.65

7.2

5.6

2.86

2.80

2.97

19577

69063

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

19486

69101

1.72

307.65

2.6

2.2

75.71

75.67

nmol/l

0.08

17931

63113

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

14419

46541

1.81

307.65

2.9

2.4

58.74

65.64

u/l

2.12

13483

42983

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

40751

187266

1.86

307.65

13.1

9.4

27.14

27.02

u/l

0.41

39773

181589

(3045414) Leukocytes [Presence] in Urine

4585

10960

2.22

307.65

2.2

1.8

0.01

0.04

estimate

5.16

999

2476

(3032080) INR in Blood by Coagulation assay

19711

68303

1.79

307.65

15.6

12.8

1.26

1.25

inr

3.36

16794

55651

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

5140

13872

1.97

307.65

7.4

5.6

—

(3019069) Monocytes/Leukocytes in Blood

20814

73985

1.76

307.65

7.3

5.6

8.81

8.80

0.08

19624

69323

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

13801

42537

1.90

307.65

2.4

2.0

225.87

232.39

u/l

0.18

13130

40016

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

19010

66044

1.76

307.65

7.3

5.8

1.21

mmol/l

0.04

17699

61172

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

10118

32979

1.69

307.65

1.9

1.6

1.17

1.28

mg/l

1.89

7710

25576

(3002582) Erythrocytes [#/volume] in Urine

14091

51901

1.52

305.59

3.7

2.9

74.87

100.63

e6/l

1.20

11111

37134

(3003458) Phosphate [Moles/volume] in Serum or Plasma

6137

18307

1.79

303.78

7.1

4.9

1.05

1.03

mmol/l

4.88

5717

16977

(3026008) Bacteria identified in Urine by Culture

12513

44943

1.55

303.72

3.3

2.7

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

14232

52762

1.51

297.57

3.4

3.6

2.35

mmol/l

2.73

13017

48461

(3018095) Leukocytes [#/volume] in Urine

16043

61007

1.49

296.93

4.3

3.3

86.30

102.15

e6/l

1.50

11704

39950

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

15356

57883

1.50

296.42

3.7

2.9

2.57

1.39

e6/l

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

28513

122071

1.46

280.31

3.7

2.7

48.56

44.82

u/l

9.11

27090

115491

(3015736) pH of Urine

18207

71585

1.46

280.19

3.7

2.8

6.26

6.15

31.30

10638

38685

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

10755

37897

1.55

279.68

2.6

2.1

—

(3000850) Epithelial cells [#/volume] in Urine

9915

34354

1.57

276.88

2.9

2.4

5.19

5.96

e6/l

5.68

9127

30655

(3019150) Specific gravity of Urine by Refractometry

10582

37427

1.54

268.83

4.2

3.2

1.29

1.11

kg/l

0.43

7330

22368

(3007853) Bacteria identified in Skin by Aerobe culture

5616

16964

1.75

263.50

1.9

1.6

—

(3045424) Erythrocytes [Presence] in Urine

2413

5356

2.33

262.28

2.2

1.8

0.33

0.05

estimate

0.42

771

1867

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

35999

162353

1.53

261.85

4.4

3.7

1.30

1.28

mmol/l

8.93

33648

151072

(3044889) 12 lead EKG panel

27424

117277

1.43

261.07

4.1

3.5

1656.48

3346.43

0.25

165

(3005719) IgG [Mass/volume] in Serum or Plasma

3846

10353

1.94

258.08

2.9

2.6

10.51

10.80

g/l

3.28

3581

9432

(3007461) Platelets [#/volume] in Blood

42034

197457

1.87

254.99

27.3

17.9

251.43

251.91

e9/l

0.75

41440

192123

(3010813) Leukocytes [#/volume] in Blood

42056

197654

1.86

253.06

27.3

17.9

6.80

6.70

e9/l

12.75

41364

191534

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

42045

197604

1.86

252.48

27.8

18.3

40.74

41.61

4.08

41674

195083

(3035941) MCH [Entitic mass]

42042

197597

1.86

252.11

27.1

17.8

30.29

30.25

4.18

41687

195187

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3872

10533

1.92

251.80

2.6

2.2

0.40

0.39

e6/l

0.06

3738

9846

(3024731) MCV [Entitic mean volume] in Red Blood Cells

42040

197596

1.86

251.75

27.1

17.9

90.87

90.62

22.57

41684

195184

(3026361) Erythrocytes [#/volume] in Blood

42044

197629

1.86

251.49

27.2

17.9

4.51

4.55

e12/l

63.37

41346

191540

(3000963) Hemoglobin [Mass/volume] in Blood

42050

197699

1.86

250.45

27.4

18.0

135.54

136.93

g/l

64.93

41708

195366

(3011397) Hemoglobin [Presence] in Urine by Test strip

10577

37900

1.52

250.16

4.0

3.1

0.23

0.26

0.08

101

403

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3212

8192

2.04

249.59

4.1

3.1

5.14

kpa

0.19

3064

7831

(3042936) Bacteria identified in Isolate by Culture

6528

20969

1.65

243.77

2.2

1.8

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

7591

25350

1.60

243.02

1.3

11.02

10.89

u/ml

0.04

2978

10358

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5298

16107

1.73

241.53

4.7

4.1

235.75

246.94

u/l

5.39

5018

15358

(3012095) Magnesium [Moles/volume] in Serum or Plasma

7397

24588

1.61

241.10

3.8

3.2

0.82

mmol/l

3.11

6988

23107

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

8169

27854

1.57

239.30

1.3

28.03

37.50

iu/ml

4.29

2419

8493

(3018677) aPTT in Platelet poor plasma by Coagulation assay

6825

22285

1.63

238.68

2.3

1.9

29.65

29.80

1.13

6648

21694

(3020779) Urea [Moles/volume] in Serum or Plasma

4297

12311

1.83

238.21

9.0

5.8

9.83

9.81

mmol/l

0.06

4107

11727

(4024509) Urine culture

2183

4854

2.32

235.81

2.0

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

3347

8870

1.96

233.73

1.3

1.2

268.02

260.47

u/ml

0.08

3140

8245

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

38239

175894

1.56

233.51

5.7

4.9

2.68

2.79

mmol/l

89.49

36105

164927

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3438

9221

1.94

232.02

4.3

3.4

91.51

87.27

ng/l

1.56

2998

7923

(3018418) pH of Serum or Plasma

12380

46406

1.46

231.81

4.6

3.7

7.40

12.11

9134

30795

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

37790

173446

1.54

231.46

5.2

4.4

4.57

4.70

mmol/l

114.32

35785

163536

(3009343) pH of Capillary blood

3106

8044

2.00

231.01

4.1

3.1

7.41

7.42

5.30

2614

6598

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1826

3782

2.48

229.03

4.3

3.2

24.63

24.83

mmol/l

1.87

1681

3489

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

37554

172423

1.52

223.79

5.1

4.3

1.42

1.45

mmol/l

24.21

35387

161565

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1936

4174

2.38

223.35

2.1

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5579

17580

1.67

222.17

1.9

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2760

6977

2.05

218.57

4.0

3.0

1.45

2.02

mmol/l

10.92

2015

5037

(3027945) Reticulocytes/Erythrocytes in Blood

5209

16189

1.69

217.94

2.8

2.4

1.80

1.72

6.22

4639

14425

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4719

14278

1.73

217.17

4.4

3.3

5.83

5.81

kpa

0.47

4591

13941

(3012544) pH of Venous blood

4791

14618

1.72

213.88

4.4

3.3

7.38

1.14

2982

7372

(3030467) Casts [#/volume] in Urine by Automated count

12014

45354

1.45

213.10

3.6

2.8

0.36

0.47

e6/l

5.80

9148

30894

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3444

9509

1.88

212.75

1.8

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

6125

20009

1.62

211.32

1.8

1.5

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

6157

20145

1.62

211.08

7.9

7.3

104.41

104.40

mmol/l

0.05

6152

20133

(3002032) Base excess in Venous blood by calculation

4607

13956

1.73

210.72

4.4

3.3

1.75

1.71

mmol/l

0.27

3988

12267

(3023520) Reticulocytes [#/volume] in Blood

4014

11690

1.79

209.68

2.7

2.5

70.02

68.67

e9/l

1.33

3010

8046

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5397

17166

1.65

206.29

3.1

2.4

7.77

9.41

umol/l

5.63

4743

14898

(3026493) Urate [Moles/volume] in Serum or Plasma

11261

42212

1.45

205.91

2.9

2.4

344.62

343.48

umol/l

0.52

10066

37585

(3027801) Oxygen [Partial pressure] in Arterial blood

5219

16510

1.66

203.43

8.4

7.8

12.51

12.59

kpa

0.43

5004

15809

(3021589) Normoblasts [#/volume] in Blood

18617

76342

1.38

203.37

11.9

10.3

0.00

e9/l

0.47

15520

60174

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5220

16522

1.66

203.02

8.4

7.8

5.09

5.08

kpa

0.17

4999

15830

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1773

3855

2.36

200.53

1.9

1.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

3013

8140

1.92

197.93

1.9

1.30

1.31

g/l

0.08

2803

7495

(3019977) pH of Arterial blood

5211

16614

1.65

196.65

8.4

7.8

7.41

7.42

3.25

3040

7884

(3003396) Base excess in Arterial blood by calculation

5169

16561

1.64

190.99

8.3

7.7

0.97

0.80

mmol/l

2.14

4164

13748

(36304419) Bacteria [Presence] in Urine

11472

43661

1.42

190.44

3.5

2.8

330.22

1.94

estimate

0.62

165

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5253

16946

1.63

188.77

2.0

1.7

—

(3016502) Oxygen saturation in Arterial blood

4664

14592

1.67

188.53

8.7

8.2

95.70

95.54

0.87

4494

14052

(4146454) Self-monitoring of blood glucose

567

605

4.75

186.95

2.8

2.0

—

(3020630) Protein [Mass/volume] in Serum or Plasma

3690

10829

1.77

186.88

2.6

2.4

66.62

66.40

g/l

0.85

3399

9998

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4380

13504

1.69

186.78

2.5

2.0

0.21

g/l

0.16

4109

12564

(3000494) Fungus identified in Specimen by Culture

5480

17928

1.61

185.94

1.6

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

7662

27060

1.50

185.74

3.1

2.7

1.08

1.30

e6/l

0.78

4367

12101

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2827

7647

1.91

184.61

1.8

1.6

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

3678

10893

1.75

180.32

2.8

2.4

68.21

69.88

ml/min/173m2

1.42

1494

4753

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

16991

69574

1.36

179.96

4.0

3.1

0.06

0.40

estimate

2.79

3752

16389

(3014051) Protein [Presence] in Urine by Test strip

12400

48366

1.39

176.13

3.1

2.5

0.04

0.06

0.29

268

1050

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

6253

21390

1.54

174.43

1.9

1.6

1.49

1.38

19.88

5565

18952

(36660697) Celiac disease serology panel - Serum

3918

11928

1.71

174.19

1.2

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

3907

11902

1.71

173.27

3.8

2.7

4.64

4.52

kpa

2.40

3797

11576

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3311

9638

1.78

171.65

2.4

2.3

19.63

20.76

au/ml

0.37

348

1264

(3022145) Colonoscopy Study observation

5086

16655

1.60

170.79

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

9816

37131

1.41

164.13

2.2

1.9

—

(3037121) Protein [Mass/volume] in Urine

1692

3949

2.19

162.54

3.4

3.6

455.49

499.85

mg/l

0.18

761

2107

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

6060

20933

1.52

160.47

2.4

1.9

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3068

8900

1.78

160.45

1.3

1.2

53.81

52.17

au/ml

0.14

179

665

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3422

10297

1.72

157.85

3.2

2.7

207.52

211.73

ng/l

0.19

3071

9371

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4321

13921

1.61

153.99

9.3

8.6

122.17

122.38

g/l

0.25

4226

13553

(3026782) Osmolality of Urine

8300

30778

1.43

153.32

3.2

2.5

534.16

547.34

mosm/kgh2o

5.38

7361

26730

(3014111) Lactate [Moles/volume] in Serum or Plasma

4166

13355

1.62

151.29

8.3

7.8

1.37

1.35

mmol/l

0.56

4070

13098

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

7004

25257

1.46

149.43

3.3

2.7

2.39

2.80

e6/l

1.97

3694

10236

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

6509

23162

1.48

148.39

2.5

2.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2345

6406

1.88

147.80

1.9

1.6

0.31

0.32

mg/l

0.18

1149

3215

(3029937) Albumin [Presence] in Urine by Test strip

12288

48946

1.35

147.61

4.2

3.3

0.00

estimate

0.53

4224

17674

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1811

4515

2.05

147.41

2.4

2.2

648.21

680.12

ug/l

0.08

1708

4283

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

8590

32255

1.41

147.23

1.7

24891436.78

34076798.45

pmol/l

0.84

7340

26737

(3025159) Blasts/Leukocytes in Blood

3996

12827

1.62

143.96

5.2

4.0

0.28

0.24

0.11

1025

3105

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2058

5442

1.94

142.56

1.9

39.84

39.59

u/l

0.19

1851

4869

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1485

3465

2.19

142.51

1.4

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

7997

29821

1.42

141.75

2.9

3.2

2.44

2.45

mmol/l

4.73

7150

26512

(3017181) Myelocytes/Leukocytes in Blood

4090

13258

1.60

141.48

5.0

3.9

0.92

0.99

0.72

1265

3651

(3033658) Prothrombin time (PT) actual/Normal

10765

42265

1.36

140.36

4.7

3.6

89.75

89.57

0.29

10505

41374

(3029634) Reagin Ab [Titer] in Serum by VDRL

902

1669

2.74

139.70

2.5

1.7

12.42

2.77

titre

1.12

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4391

14566

1.57

137.66

2.8

2.3

48.51

49.17

u/l

0.02

3730

12442

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2082

5608

1.90

136.59

5.5

4.4

1.68

1.65

0.43

1976

5244

(3002179) Metamyelocytes/Leukocytes in Blood

3905

12653

1.60

134.97

4.8

3.8

0.66

0.72

1229

3344

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2327

6541

1.83

134.01

4.2

3.5

48.98

47.32

2.16

2295

6446

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2185

6022

1.86

133.76

1.8

1.6

1.48

1.53

g/l

1.06

1892

5125

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1841

4814

1.96

131.44

2.2

4.22

4.18

g/l

0.85

1692

4432

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1839

4810

1.96

131.20

2.2

3.67

3.86

g/l

5.63

1692

4425

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1842

4822

1.95

131.10

2.2

2.1

7.32

7.37

g/l

0.53

1692

4431

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1450

3474

2.13

130.38

1.5

1.4

276.18

269.04

ug/g

0.53

833

2022

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1435

3433

2.13

129.49

1.4

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

771

1366

2.86

128.83

2.1

1.6

1747.69

5274.29

titre

0.78

(3021440) Promyelocytes/Leukocytes in Blood

3906

12794

1.58

128.75

5.1

3.9

0.10

0.14

1.52

1085

3197

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

669

1116

3.04

123.52

1.5

1.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

2017

5574

1.85

122.24

2.0

1.7

7.00

7.80

iu/ml

0.47

532

1104

(3011288) Drugs identified in Urine by Screen method Nominal

1932

5291

1.87

120.34

3.8

2.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

668

1132

2.99

120.24

1.5

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

679

1163

2.96

120.09

1.5

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1346

3244

2.11

119.16

1.4

1.3

517.31

574.86

mg/l

1.39

1284

3122

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

3301

10623

1.60

116.53

1.5

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1721

4595

1.91

115.53

2.3

2.2

2.88

2.98

g/l

3.68

1572

4207

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2775

8562

1.67

115.50

7.3

6.2

24.40

24.42

mmol/l

0.10

2655

8127

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

743

1375

2.74

115.02

1.7

1.6

346.93

393.49

mu/l

1.03

590

1131

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

637

1080

2.99

114.57

1.5

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

638

1083

2.98

114.53

1.5

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

9976

39761

1.33

113.39

5.1

4.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

8049

31049

1.36

113.38

1.8

1.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

634

1079

2.97

113.33

1.5

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1740

4699

1.89

112.91

1.3

1.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2760

8558

1.66

112.65

4.7

3.4

24.10

24.19

mmol/l

0.81

2727

8453

(3000330) Specific gravity of Urine by Test strip

2234

6544

1.75

111.89

3.5

2.9

1.02

ratio

3.34

2022

5677

(3027273) Bicarbonate [Moles/volume] in Venous blood

2116

6115

1.77

110.91

3.7

2.9

25.16

25.24

mmol/l

0.45

2043

5884

(3007930) Methemoglobin/Hemoglobin.total in Blood

1884

5272

1.83

109.60

5.8

4.5

0.85

0.89

4.65

1784

4916

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1878

5263

1.82

108.73

2.0

1.8

1.87

2.54

ug/l

1.28

1657

4684

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

13430

56053

1.29

107.78

5.2

4.9

3.18

3.17

ug/l

0.02

12207

50811

(3045716) Anion gap in Serum or Plasma by calculation

574

952

3.05

106.99

3.4

3.2

10.31

11.48

mmol/l

8.40

568

944

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1191

2853

2.12

106.98

1.3

1.2

3.79

3.70

mmol/l

1.64

1121

2706

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1448

3751

1.97

105.85

1.3

1.2

37.25

39.34

u/ml

0.09

213

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2382

7216

1.69

105.83

1.1

14.88

4.67

u/ml

0.35

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1960

5617

1.78

105.52

1.7

1.5

17.23

12.92

iu/ml

0.47

141

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1531

4084

1.91

102.91

1.9

1.6

1.18

1.20

g/l

1.39

1456

3942

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1236

3059

2.05

102.15

1.3

1.2

66.12

43.45

u/ml

0.32

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1195

2920

2.08

102.07

1.3

1.2

7.03

17.64

u/ml

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

3033

9863

1.58

102.00

1.3

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2816

8996

1.61

101.92

3.7

2.8

129.74

131.18

g/l

2.42

2741

8743

(3000991) Gas panel - Venous blood

3902

13463

1.50

100.49

10.0

8.6

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1483

3954

1.91

99.79

1.9

1.6

0.23

0.24

g/l

1.23

1404

3801

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

575

1010

2.88

97.54

1.8

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1349

3515

1.95

96.94

1.3

1.2

9.29

8.69

u/ml

0.09

209

448

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1350

3522

1.95

96.67

1.3

1.2

5.60

10.07

u/ml

0.71

138

292

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1566

4302

1.85

96.32

2.3

2.2

10.27

10.39

g/l

0.41

1406

3886

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1642

4590

1.82

95.65

3.1

2.8

24.57

24.83

mmol/l

1.62

1619

4493

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2835

9284

1.57

92.22

3.4

3.6

4.51

4.56

pmol/l

2.05

2545

8470

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1561

4347

1.83

91.99

2.8

2.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1153

2896

2.02

91.61

1.3

1.2

260.37

247.15

u/ml

0.80

707

1861

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

529

920

2.91

91.28

1.8

1.6

—

(3017354) Segmented neutrophils/Leukocytes in Blood

548

976

2.84

90.81

3.7

2.9

56.78

58.18

0.65

471

852

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2125

6506

1.67

90.47

2.4

2.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1179

3000

2.00

90.45

1.5

1.4

4368.12

1024.00

e6/l

0.53

930

2271

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1117

2789

2.03

90.15

1.3

1.2

2.95

6.57

u/ml

1.03

181

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1548

4335

1.82

89.60

2.3

2.4

0.83

0.80

g/l

0.11

1356

3679

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2682

8741

1.57

88.95

10.4

10.2

24.23

24.29

mmol/l

0.38

2607

8543

(3003327) Ova and parasites identified in Stool by Light microscopy

1766

5171

1.74

88.19

1.7

1.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1829

5417

1.72

87.78

1.3

1.2

1.05

0.65

u/ml

0.67

132

480

(3022621) pH of Urine by Test strip

3492

12097

1.48

87.60

2.6

2.3

6.06

6.13

4.24

2325

7838

(3024980) IgG subclass 4 [Mass/volume] in Serum

918

2147

2.17

87.39

1.7

1.5

0.77

0.83

g/l

0.73

745

1542

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1294

3450

1.91

86.99

2.0

12.05

10.81

mg/l

1.95

1212

3282

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1647

4744

1.77

86.95

1.5

1.6

5.30

2.32

iu/ml

0.32

310

858

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1814

5375

1.72

86.91

1.6

1.7

16.86

16.23

u/ml

0.15

419

1708

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1161

2982

1.98

86.79

1.5

1.4

24.16

36.95

e6/l

0.65

865

2102

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4067

14542

1.44

86.78

4.1

4.6

26.03

34.88

ug/l

0.75

3302

11693

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2928

9796

1.53

86.49

10.5

9.9

1.38

1.30

4.28

2908

9739

(3026250) Tacrolimus [Mass/volume] in Blood

302

369

4.12

85.82

42.1

38.4

7.40

7.41

ug/l

0.03

280

338

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2853

9507

1.54

85.78

10.7

10.2

0.64

0.63

1.07

2830

9461

(3048929) Epstein Barr virus Ab [Presence] in Serum

1848

5541

1.70

84.85

1.3

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1138

2941

1.96

83.62

1.5

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2571

8415

1.56

83.58

1.1

1.0

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1129

2910

1.97

83.57

1.5

1.3

23.13

23.37

u/ml

0.02

(3004616) Nuclear Ab [Presence] in Serum

633

1276

2.51

83.43

1.3

1.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2916

9848

1.52

82.37

10.6

10.1

94.08

93.81

1.51

2907

9816

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1303

3553

1.86

81.88

1.5

1.4

11.60

11.25

iu/ml

0.03

(3034770) Mitochondria Ab [Titer] in Serum

1403

3926

1.82

81.34

1.3

1.2

735.81

1121.27

titre

1.27

102

(3047181) Lactate [Moles/volume] in Blood

1417

3979

1.81

81.24

6.4

4.9

1.35

1.29

mmol/l

1.03

1253

3408

(3018405) Lactate [Moles/volume] in Arterial blood

1512

4334

1.78

81.07

3.8

3.9

1.40

1.46

mmol/l

1.08

1487

4257

(3019420) Tryptase [Mass/volume] in Serum or Plasma

353

511

3.48

80.71

1.5

1.6

10.29

7.88

ug/l

0.48

318

449

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

3248

11269

1.48

80.58

2.4

1.7

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

32708

153561

1.24

80.48

21.4

15.0

13.59

13.50

28.56

32391

150830

(3020891) Body temperature

2085

6545

1.63

80.46

4.6

4.3

36.92

36.90

°c

2.10

2067

6467

(3007566) Smooth muscle Ab [Titer] in Serum

1425

4023

1.80

80.29

1.3

1.2

101.29

129.10

titre

0.60

140

435

(3023183) Ammonium ion [Moles/volume] in Plasma

1089

2820

1.96

79.56

3.2

2.3

34.31

34.83

umol/l

0.18

1008

2523

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1080

2798

1.96

78.80

7.2

3.8

790.16

3617.52

iu/ml

0.64

171

285

(3009466) Valproate [Moles/volume] in Serum or Plasma

782

1788

2.21

78.56

5.8

4.8

367.19

358.89

umol/l

0.76

692

1538

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

393

627

3.16

77.96

2.8

2.2

217.47

239.26

e6/l

0.96

322

509

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

714

1579

2.29

77.42

6.9

5.4

11.62

11.44

mg/l

0.43

658

1447

(3009214) Lutropin [Units/volume] in Serum or Plasma

1728

5228

1.68

76.68

1.5

1.3

8.91

9.03

u/l

0.13

1388

4185

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3830

13875

1.42

75.56

2.5

1.8

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2187

7072

1.58

74.66

2.5

2.2

6561.22

6788.82

u/l

0.11

870

2867

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

778

1815

2.17

74.53

1.4

1.3

22.83

26.22

u/l

1.94

631

1533

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

869

2123

2.07

74.23

3.4

2.1

1365.78

3579.75

u/ml

1.24

114

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2524

8492

1.52

72.27

11.3

9.6

16.09

16.23

1.44

2429

8160

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2340

7743

1.54

72.25

3.3

2.6

1.30

1.27

0.66

2326

7707

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1043

2755

1.92

72.01

1.6

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

5541

21483

1.33

71.87

2.0

1.7

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

380

627

3.06

71.57

2.7

2.1

525.91

515.31

e6/l

0.10

294

471

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

422

747

2.85

70.77

3.1

1.6

—

(4198724) Urine methamphetamine measurement

342

532

3.24

70.55

3.4

1.8

—

(3008037) Lactate [Moles/volume] in Venous blood

1126

3079

1.85

70.11

3.1

2.7

1.55

1.66

mmol/l

2.35

1096

2995

(3004809) Band form neutrophils/Leukocytes in Blood

813

1982

2.08

69.83

3.8

2.9

1.69

1.59

0.25

721

1784

(3017446) Testosterone [Moles/volume] in Serum or Plasma

4343

16285

1.37

69.75

2.5

2.1

13.16

13.39

nmol/l

1.00

3933

15003

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

33110

156499

1.22

68.48

22.7

14.8

332.74

333.10

g/l

9.26

32909

155423

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

679

1552

2.21

68.30

1.2

1.1

14.05

20.94

u/ml

0.35

(3025941) Bacteria identified in Stool by Culture

2544

8675

1.50

68.29

1.3

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

436

806

2.73

67.78

1.8

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

436

806

2.73

67.78

1.8

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

436

806

2.73

67.78

1.8

1.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2297

7684

1.53

67.42

3.4

2.6

0.62

0.41

2286

7662

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1318

3833

1.75

67.22

2.2

0.03

0.02

g/l

0.64

1205

3387

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

372

633

2.96

66.70

2.9

2.2

0.69

0.65

e9/l

0.52

357

596

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

676

1563

2.19

66.19

2.5

2.4

27.37

28.43

iu/ml

0.07

118

(44806118) Parainfluenza type 4 nucleic acid detection

664

1524

2.20

66.16

1.6

1.3

—

(44790049) Parainfluenza type 3 nucleic acid detection

664

1525

2.20

66.06

1.6

1.3

—

(44790048) Parainfluenza type 2 nucleic acid detection

664

1526

2.20

65.96

1.6

1.3

—

(44790047) Parainfluenza type 1 nucleic acid detection

664

1528

2.20

65.75

1.6

1.3

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

369

631

2.95

65.63

13.8

13.0

0.61

mmol/l

0.21

334

571

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1018

2755

1.87

65.42

1.5

1.3

149.73

146.67

au/ml

0.31

269

821

(3003129) Base excess in Capillary blood by calculation

554

1180

2.37

65.27

2.3

1.9

0.35

0.54

mmol/l

0.51

530

1142

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

460

895

2.59

65.06

2.2

2.3

19.67

18.87

nmol/l

0.82

437

860

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1257

3648

1.75

64.56

1.8

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

1250

3639

1.74

63.51

4.2

3.89

3.91

mmol/l

0.37

1237

3610

(3011412) CD3 cells [#/volume] in Blood

513

1070

2.42

63.18

2.6

2.1

1221.79

1119.77

e6/l

1.33

434

945

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

264

372

3.57

62.76

2.6

2.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

429

821

2.64

62.62

1.2

56.87

61.57

u/ml

0.09

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1418

4302

1.67

62.17

3.4

3.2

49.71

44.19

mg/l

0.27

1250

3323

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

339

570

3.00

62.02

2.7

2.4

41.21

39.41

0.69

176

283

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

499

1040

2.42

61.57

1.2

39.13

45.53

u/ml

0.19

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1254

3694

1.72

61.15

2.2

0.00

g/l

0.03

1115

3226

(3034860) Kappa light chains.free [Mass/volume] in Serum

1417

4319

1.67

61.05

3.4

3.2

88.77

60.13

mg/l

0.35

1245

3340

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1489

4601

1.64

60.90

3.4

2.9

0.33

0.35

iu/ml

1.92

847

2399

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1220

3572

1.73

60.77

1.7

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

871

2295

1.92

60.58

1.3

1.2

333.90

324.78

titre

0.03

183

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1272

3773

1.71

60.53

1.2

1.1

4.49

3.95

0.59

165

703

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

473

969

2.46

60.47

2.9

2.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1068

3020

1.79

59.81

1.2

43.49

48.92

u/ml

0.35

280

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

588

1339

2.22

59.72

1.1

15.19

7.64

au/ml

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

10543

45132

1.22

59.65

4.3

4.1

21.98

0.01

4869

20741

(3020961) Endomysium IgA Ab [Titer] in Serum

2229

7611

1.49

59.26

1.1

147.58

228.00

titre

1.01

247

(42529406) Shigella sp [Presence] in Stool by Culture

1253

3726

1.71

59.09

1.2

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

872

2319

1.90

59.04

1.3

1.2

221.82

85.14

titre

0.60

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1180

3453

1.73

58.89

2.2

2.3

0.00

g/l

-0.00

1114

3220

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

571

1299

2.22

58.14

1.1

39.52

63.22

au/ml

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1246

3721

1.70

57.87

1.2

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

568

1300

2.21

57.03

1.4

1.3

2.94

3.00

g/l

0.34

441

801

(3044927) Protein electrophoresis panel - Urine

446

915

2.46

56.88

1.2

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

897

2439

1.86

56.84

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

567

1300

2.20

56.70

1.4

1.3

0.40

0.42

g/l

0.71

440

798

(3027135) IgG subclass 1 [Mass/volume] in Serum

567

1301

2.20

56.60

1.4

1.3

6.69

6.92

g/l

0.70

439

801

(4062490) Immunoglobulin typing, IgG

562

1287

2.20

56.36

1.4

1.3

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

116

7.29

56.28

7.6

8.3

70.48

71.46

0.10

(3038026) Centromere Ab [Units/volume] in Serum

373

702

2.68

56.22

1.2

42.17

44.50

u/ml

0.05

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1274

3859

1.67

56.17

3.2

3.1

3.00

7.38

ratio

0.59

801

1755

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

960

2682

1.81

55.91

1.7

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1234

3716

1.68

55.59

1.2

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

423

856

2.49

55.48

3.3

2.7

65.04

45.99

mg/l

0.55

315

592

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

467

992

2.37

55.41

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

450

942

2.41

55.07

1.1

258.55

273.16

mg/l

0.61

401

820

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

26.78

54.63

1.1

1.0

0.03

0.15

u/ml

0.46

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

836

2257

1.87

54.15

1.3

40.04

27.85

u/l

1.45

738

1936

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

462

989

2.36

53.94

1.2

1.1

39.93

47.61

mg/l

2.35

398

803

(3041096) Erythrocytes [Presence] in Urine by Automated

12043

52635

1.20

53.91

3.4

2.8

0.11

0.18

estimate

0.38

3598

15772

(3010375) cycloSPORINE [Mass/volume] in Blood

253

386

3.30

53.85

28.1

25.7

116.46

126.93

ug/l

0.89

199

335

(3003181) Sodium [Moles/volume] in Urine

847

2304

1.86

53.62

1.4

63.56

61.60

mmol/l

0.59

677

1797

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

547

1275

2.17

52.63

2.2

1.7

23.77

30.20

mg/l

2.09

201

491

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

16164

72614

1.18

52.60

1.9

1.8

1.40

1.35

mmol/l

7.77

14095

60731

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

531

1224

2.19

52.47

1.1

1.0

—

(3036489) Thrombin time

1747

5811

1.53

52.42

2.4

1.9

21.24

20.92

0.91

1532

5125

(3021387) Prolactin [Units/volume] in Serum or Plasma

1981

6778

1.49

52.04

1.7

1.6

290.08

286.32

mu/l

0.22

1807

6042

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

326

600

2.74

51.22

1.1

4.84

9.44

nmol/l

0.83

137

(3000475) Leukocytes [#/volume] in Synovial fluid

1109

3319

1.69

51.11

1.6

15149.15

13708.86

e6/l

0.29

788

2253

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

980

2835

1.75

50.89

2.6

1.6

0.88

0.85

nmol/l

0.62

801

2508

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

327

606

2.72

50.75

1.4

1.3

—

(3049717) Cytology report of Urine Cyto stain

1569

5133

1.55

50.69

2.6

2.7

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

316

578

2.75

50.22

1.6

1.21

1.26

nmol/l

0.30

226

478

(3020191) Ethanol [Moles/volume] in Serum or Plasma

495

1134

2.20

49.66

1.5

1.3

1.28

promille

0.01

390

875

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

270

454

2.99

49.51

2.0

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

270

454

2.99

49.51

2.0

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

270

454

2.99

49.51

2.0

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

270

454

2.99

49.51

2.0

1.7

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1466

4763

1.56

48.81

3.0

2.3

3.50

3.69

g/l

4.93

1395

4566

(21494815) CD4 cells/Lymphocytes in Specimen

466

1050

2.24

48.60

2.6

2.0

38.72

38.13

0.32

457

1036

(3008898) HLA-B27 [Presence]

1721

5801

1.51

48.53

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1062

3193

1.68

48.13

1.4

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1849

6348

1.48

47.71

2.0

1.7

39.70

40.14

nmol/l

0.34

1797

6272

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

317

599

2.67

47.52

1.4

1.3

—

(3037756) Immunofixation for Serum or Plasma

885

2542

1.76

47.10

1.6

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1703

5767

1.50

46.97

1.3

213.05

227.22

miu/ml

0.80

757

2821

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

676

1795

1.90

46.06

1.3

0.22

0.30

nmol/l

0.51

120

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

147

166

4.45

45.96

2.0

1.3

—

(1175426) CD3 cells/Lymphocytes in Blood

415

912

2.29

45.83

2.2

1.9

73.67

72.54

0.68

392

884

(3042733) HLA Ab [Presence] in Serum

211

318

3.34

45.81

4.7

5.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

707

1911

1.87

45.69

1.1

1.51

g/l

0.09

648

1770

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

404

882

2.31

45.28

2.2

1.9

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

320

630

2.56

44.43

1.7

1.3

21.40

26.96

umol/l

2.24

295

571

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

412

918

2.26

44.14

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

396

871

2.29

43.68

2.2

1.8

14.51

15.51

0.99

383

853

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

228

377

3.04

43.03

2.1

1.7

29.95

29.22

0.28

215

360

(3010838) Calcium [Moles/time] in 24 hour Urine

776

2214

1.77

42.28

1.9

2.0

5.02

5.38

mmol/24h

2.00

689

2026

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

128

138

4.66

42.11

1.4

1.2

1.17

1.18

mmol/l

0.59

128

138

(3014271) Vancomycin [Susceptibility]

239

413

2.91

41.99

2.9

2.7

—

(3016244) Insulin [Units/volume] in Serum or Plasma

353

751

2.37

41.89

3.3

3.0

26.34

27.22

mu/l

0.14

331

720

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

194

294

3.32

41.83

1.6

1.8

39.68

41.03

g/l

1.72

194

294

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1402

4672

1.52

41.67

1.5

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1367

4533

1.53

41.56

2.9

2.2

186.85

191.67

1.07

1303

4324

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1480

4995

1.50

41.45

2.7

2.0

93.17

92.69

0.32

1433

4801

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1245

4049

1.56

41.27

1.1

6.05

4.78

eliau/ml

0.42

144

676

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

427

999

2.15

40.84

1.1

286.12

284.96

mg/l

0.10

391

920

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3059

11768

1.33

40.53

1.2

138.27

148.97

u/ml

0.59

1111

4672

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

6.83

40.35

1.0

0.11

0.34

u/ml

0.44

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1397

4691

1.51

40.08

2.0

1.8

206.64

207.52

pmol/l

0.09

1322

4497

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1054

3322

1.60

39.86

1.5

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

650

1790

1.83

39.73

1.3

0.61

3.19

nmol/l

1.27

628

1719

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

713

2023

1.78

39.59

1.2

—

14.43

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1427

4829

1.50

39.46

4.4

2.8

1.50

1.46

mg/l

1.24

1330

4405

(3013005) Retinol [Moles/volume] in Serum or Plasma

263

498

2.66

39.38

2.1

1.5

1.92

2.00

umol/l

0.78

247

444

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

417

981

2.14

39.37

1.3

1.2

2.05

2.17

mmol/l

0.97

389

911

(3039000) Anion gap in Blood by calculation

903

2747

1.66

39.23

8.1

5.8

11.55

11.36

mmol/l

0.73

809

2430

(3018572) Chloride [Moles/volume] in Blood

903

2748

1.66

39.18

8.1

5.8

105.07

104.96

mmol/l

0.25

809

2431

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

316

659

2.41

39.16

1.5

1.4

6.21

5.93

u/l

0.17

281

571

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

999

3124

1.62

39.00

2.4

121.74

112.86

ug/min

0.20

635

1853

(3024928) Oxygen saturation in Venous blood

1143

3693

1.57

38.98

3.8

2.7

62.33

61.74

0.37

1100

3582

(3038515) Glucose [Moles/volume] in Venous blood

905

2763

1.66

38.79

3.3

2.8

7.48

7.75

mmol/l

1.64

881

2691

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

272

529

2.59

38.74

2.4

1.6

137.63

110.73

umol/l

0.72

142

251

(40768443) Skin Pathology biopsy report

1893

6796

1.41

38.55

1.2

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

352

778

2.28

38.48

1.2

1.3

0.61

0.68

ratio

0.84

218

368

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

220

382

2.90

38.40

1.5

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

752

2190

1.73

38.26

1.2

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

220

383

2.89

38.23

1.5

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2237

8285

1.37

37.93

1.4

—

(21494755) Public health laboratory ask at order entry panel

3790

23560

0.79

37.67

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

857

2606

1.66

37.31

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1197

3948

1.53

37.30

1.1

2.20

2.42

u/ml

0.26

680

1919

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

147

199

3.71

37.09

2.2

2.0

15.70

16.80

umol/l

0.46

147

199

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

196

325

3.03

36.91

2.0

1.4

20669.17

3881.03

u/ml

0.55

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

573

1555

1.86

36.68

1.3

0.22

0.21

nmol/l

0.17

457

1189

(3026389) Candida sp identified in Specimen by Organism specific culture

661

1883

1.77

36.26

1.4

1.2

—

(3006245) CD3-CD19+ cells/cells in Blood

228

419

2.74

36.11

2.4

2.0

8.86

9.72

0.44

209

396

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

884

2738

1.63

35.87

1.5

1.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

514

1359

1.91

35.59

3.2

3.5

4.98

13.44

nmol/l

0.84

497

1322

(3003888) Timothy IgE Ab [Units/volume] in Serum

1055

3420

1.56

35.49

1.1

5.42

5.63

u/ml

0.15

611

1706

(3042111) Morphology [Interpretation] in Bone marrow Narrative

722

2130

1.71

35.14

1.7

1.6

—

(40761536) Microorganisms panel - Urine sediment

2796

17869

0.77

34.72

4.4

3.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

750

2245

1.69

34.65

1.5

1.3

14.23

12.73

u/ml

0.09

(21494434) Karyotype in Bone marrow

389

939

2.09

34.53

1.2

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

901

2833

1.61

34.45

1.4

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

355

827

2.16

34.41

1.2

—

(3002256) Pathology report gross observation

5382

22602

1.22

34.28

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

349

809

2.17

34.23

1.2

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

323

726

2.24

34.06

3.0

3.8

101.07

181.01

nmol/l

1.56

317

717

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

156

235

3.34

34.04

3.6

2.9

2.04

ratio

0.00

143

215

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

312

691

2.27

34.02

1.1

1.06

1.14

u/l

0.65

125

302

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

190

326

2.93

33.90

2.3

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

190

326

2.93

33.90

2.3

1.9

—

(3024932) HLA-DR beta [Type]

178

294

3.04

33.79

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

499

1331

1.89

33.70

1.4

1.3

1.49

1.43

nmol/l

0.41

446

1210

(3020876) Protein [Mass/time] in 24 hour Urine

551

1519

1.83

33.65

2.5

2.6

1.39

1.30

g/24h

0.26

328

955

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

270

563

2.41

33.56

1.4

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1686

6082

1.41

33.39

1.4

—

(3024471) HLA-A [Type]

181

305

2.98

33.28

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

190

331

2.89

33.06

2.3

1.9

—

(3023410) Appearance of Cerebral spinal fluid

532

1460

1.84

32.96

1.7

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

803

2481

1.63

32.94

3.3

3.1

0.82

0.81

nmol/l

0.34

623

2036

(3008295) Osmolality of Serum or Plasma

533

1467

1.83

32.73

1.5

1.4

280.09

278.62

mosm/kgh2o

0.59

411

1136

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1381

4828

1.45

32.46

2.1

1.8

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

402

1009

2.01

32.26

1.3

1.2

85.95

80.63

0.90

(3028626) Oxygen [Partial pressure] in Capillary blood

1193

4057

1.49

32.25

3.8

3.1

8.38

8.27

kpa

1.40

1162

3954

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

763

2343

1.64

32.06

1.3

1.2

4.81

3.80

u/ml

0.69

349

1110

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

373

917

2.05

31.64

23.4

18.4

1399.56

3038.81

nmol/l

0.49

357

890

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1294

4496

1.46

31.42

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1011

3346

1.53

31.07

1.1

0.95

1.12

u/ml

0.39

491

1350

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

304

694

2.20

30.98

1.0

42.96

41.92

ng/l

0.13

206

546

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

302

690

2.20

30.72

1.0

306.11

338.13

ng/l

0.94

209

549

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

612

1792

1.72

30.65

1.2

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

810

2558

1.60

30.48

1.9

1.5

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

356

873

2.05

30.42

16.6

13.4

4517.25

1973.12

nmol/l

0.29

338

844

(3000093) Morphology [Interpretation] in Blood Narrative

448

1194

1.89

30.38

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

302

694

2.19

30.32

1.0

745.12

728.69

ng/l

0.21

205

525

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

484

1325

1.84

30.27

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

451

1207

1.88

30.22

1.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2867

11365

1.28

30.20

9.7

7.4

24.82

24.72

mmol/l

0.74

2851

11262

(40757494) Bilirubin.total [Moles/volume] in Blood

254

542

2.36

30.13

2.4

2.0

22.07

51.12

umol/l

2.17

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1146

3922

1.48

30.04

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

455

1225

1.87

29.95

3.9

3.7

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1450

5199

1.41

29.73

3.7

3.8

2897.05

3363.18

u/ml

0.08

1258

4499

(3039162) Centromere protein B Ab [Units/volume] in Serum

578

1686

1.73

29.36

1.3

1.2

57.14

54.47

u/ml

0.06

100

(3000060) B lymphocytes [#/volume] in Blood

178

323

2.77

28.95

2.2

1.7

0.19

1.54

e9/l

0.77

131

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

318

761

2.10

28.95

2.7

1.7

96.27

97.46

0.22

301

713

(4268621) Lupus anticoagulant assay

573

1677

1.72

28.78

2.3

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

653

1984

1.66

28.63

3.3

2.6

478.38

684.55

u/ml

0.19

648

1946

(3010503) CD19 cells [#/volume] in Blood

303

717

2.13

28.38

2.9

2.2

220.12

183.85

e6/l

0.14

290

701

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

568

1667

1.72

28.26

1.1

1.0

—

(3052851) Hemolysis interference index of Serum or Plasma

1202

4207

1.44

28.12

3.4

3.0

1.94

2.04

index

0.19

640

1997

(3010726) Horse dander IgE Ab [Units/volume] in Serum

998

3368

1.50

28.04

1.1

1.50

2.00

u/ml

1.33

566

1508

(4195642) Thrombophilia screening test

712

2228

1.61

27.85

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

382

994

1.93

27.83

1.6

1.3

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

238

513

2.33

27.68

2.2

1.4

28.77

29.06

umol/l

0.14

224

468

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

335

834

2.02

27.57

1.5

26.38

26.49

u/ml

0.01

166

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

496

1411

1.77

27.48

1.2

33.50

26.18

nmol/l

0.48

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

369

954

1.95

27.39

1.1

1.41

3.30

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

294

699

2.12

27.24

1.4

1.2

392.86

650.98

titre

0.43

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

284

666

2.15

27.22

1.4

1.2

67.78

112.33

titre

0.51

(3042517) Benzodiazepines panel - Urine

122

3.99

26.98

2.7

3.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1200

4234

1.43

26.90

2.0

8.35

8.19

iu/l

0.01

505

1785

(3017817) Protein [Mass] in Urine collected for unspecified duration

406

1093

1.87

26.79

2.8

2.4

1130.38

1115.64

0.05

401

1078

(3044242) Glucose [Moles/volume] in Arterial blood

285

674

2.13

26.77

1.7

2.1

7.87

7.90

mmol/l

0.04

285

674

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

805

2624

1.55

26.54

1.1

12560.66

828.33

iu/ml

0.46

177

506

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

745

2390

1.57

26.32

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

375

990

1.91

26.24

1.1

—

0.22

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

182

354

2.58

26.12

2.2

1.9

65.79

61.20

ug/l

0.21

176

349

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

770

2495

1.56

26.07

1.3

1.2

3.51

3.53

u/ml

0.01

274

960

(3047007) Chlamydophila sp Ab [Presence] in Serum

699

2217

1.59

25.92

1.2

—

(3048879) Bone marrow aspiration report

127

201

3.17

25.89

2.1

1.6

2.00

—

(3023419) Bacteria identified in Sputum by Culture

558

1675

1.68

25.65

3.1

2.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

819

2701

1.53

25.65

1.1

16.45

14.56

au/ml

0.35

200

900

(3003694) ABO and Rh group [Type] in Blood

12068

55154

1.13

25.61

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

7723

34248

1.16

25.52

3.1

3.0

0.76

0.79

ug/l

1.75

4931

20548

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

657

2064

1.60

25.34

1.1

3.45

2.71

0.46

106

425

(40759836) Histone Ab [Presence] in Serum by Immunoblot

397

1083

1.85

25.20

1.2

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

698

2231

1.58

25.08

1.5

1.3

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

404

1111

1.83

25.02

1.2

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

189

385

2.47

24.80

1.2

0.29

0.31

g/l

1.40

152

292

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

264

625

2.12

24.78

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

393

1076

1.84

24.68

1.2

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

535

1605

1.68

24.67

1.1

2.03

2.02

iu/ml

—

(3017704) Immunofixation for Urine

240

548

2.20

24.58

1.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

392

1076

1.83

24.43

1.2

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

6.65

24.23

3.2

2.2

2.45

2.23

mg/l

0.22

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

704

2277

1.56

24.06

1.2

1.1

114.79

117.04

1.05

648

2057

(3006922) Hepatitis E virus Ab [Presence] in Serum

418

1179

1.78

23.90

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

380

1042

1.84

23.78

1.2

—

(3016038) Potassium [Moles/volume] in Urine

325

847

1.93

23.67

1.3

1.2

36.07

34.83

mmol/l

0.40

285

749

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

6080

26612

1.17

23.66

1.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

151

283

2.68

23.29

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

185

385

2.42

23.28

1.4

14.97

14.92

pmol/l

0.02

153

334

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

4.18

23.24

1.0

1.1

0.83

0.39

u/ml

0.38

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

354

956

1.86

23.23

1.8

1.4

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

126

215

2.94

22.87

1.1

1.3

5.84

13.75

u/ml

0.74

136

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

207

458

2.27

22.83

1.1

1.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

142

3.47

22.77

1.8

1.3

8205.33

15662.50

u/ml

0.29

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

386

1079

1.80

22.75

1.2

107.41

112.54

pmol/l

0.95

386

1079

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

206

456

2.27

22.70

1.1

1.2

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

174

357

2.45

22.56

1.2

108.58

110.30

0.31

153

321

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

217

493

2.21

22.54

1.1

342.86

347.14

ng/l

0.01

149

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

288

732

1.98

22.53

1.7

1.4

1225115.05

1694031.29

iu/ml

0.34

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

136

3.51

22.45

2.2

1.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

758

2532

1.51

22.45

1.2

0.75

1.29

1.43

154

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

286

729

1.97

22.21

1.1

—

(3011985) Renin [Units/volume] in Plasma

638

2060

1.56

22.02

1.5

67.74

68.15

mu/l

0.01

584

1852

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

121

3.65

21.96

2.3

1.9

—

(1761482) Bacteria [#/volume] in Urine by Culture

969

3418

1.43

21.83

4.3

3.3

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

105

3.87

21.80

1.0

1.1

0.06

6.97

u/ml

0.65

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

106

3.84

21.55

1.0

1.1

0.03

1.51

u/ml

0.85

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

240

581

2.08

21.39

2.4

52.32

51.40

umol/l

0.16

220

501

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

150

294

2.56

21.32

1.1

—

(4034850) Laboratory test

965

6707

0.72

21.29

11.5

8.3

—

(3035285) Chloride [Moles/volume] in Venous blood

497

1526

1.64

21.09

2.3

2.1

105.65

105.53

mmol/l

0.22

490

1510

(3041354) Potassium [Moles/volume] in Venous blood

497

1526

1.64

21.09

2.3

2.1

4.06

4.07

mmol/l

0.32

490

1511

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

260

654

2.00

20.97

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

243

596

2.05

20.95

1.7

1.8

150.17

151.61

0.08

232

567

(3010144) Erythrocytes [#/volume] in Synovial fluid

418

1229

1.71

20.83

1.4

104337.87

95180.63

e6/l

0.11

277

814

(3028433) Virus identified in Specimen by Culture

154

310

2.50

20.79

1.2

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

102

162

3.16

20.79

1.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

162

336

2.42

20.60

1.5

1.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

246

611

2.02

20.53

1.7

1.5

3.90

4.81

nmol/l

0.26

194

503

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

544

1723

1.59

20.41

1.2

1.1

96.64

97.62

0.34

512

1623

(3006270) Folate [Moles/volume] in Blood

372

1064

1.76

20.40

1.2

1.1

340.90

394.02

nmol/l

4.14

319

906

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

196

446

2.21

20.34

1.1

7.93

8.09

u/ml

0.02

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

847

2953

1.45

20.34

3.5

4.2

989.36

1191.07

u/ml

0.18

779

2694

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

192

437

2.21

19.93

1.0

11.40

10.48

u/ml

0.19

129

319

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

370

1070

1.74

19.57

1.2

—

(3045142) Bone marrow Pathology biopsy report

467

1441

1.63

19.48

1.4

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

+∞

19.48

1.1

0.0

0.05

—

u/ml

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

148

3.19

19.45

1.3

1.1

—

(40765096) Chromosome analysis panel by Banding

152

316

2.42

19.27

1.1

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

101

168

3.02

19.20

2.1

3.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

255

659

1.95

19.14

1.5

1.6

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

363

1051

1.74

19.14

1.5

1.4

12.47

12.37

umol/l

0.09

335

997

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

223

549

2.04

19.10

2.8

2.5

153.22

144.40

nmol/l

0.62

201

452

(3032057) Clostridioides difficile [Presence] in Stool

158

3.08

19.06

2.1

1.8

—

(3024263) Appearance of Synovial fluid

240

609

1.98

18.96

1.9

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

2292

9344

1.24

18.96

1.4

1.3

23.83

26.40

iu/l

3.21

1941

7859

(4035726) Immunohistochemistry procedure

3305

13987

1.20

18.88

1.4

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

388

1150

1.70

18.85

1.2

206.00

161.56

titre

—

(3018333) Ribosomal P Ab [Presence] in Serum

360

1045

1.73

18.82

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

141

287

2.47

18.68

1.7

1.5

8.76

9.47

ug/l

0.91

141

287

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

388

1153

1.69

18.68

1.2

171.97

204.85

titre

0.31

167

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

249

644

1.94

18.66

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

444

1368

1.63

18.66

1.2

67.84

68.75

u/l

0.06

394

1183

(40768446) Kidney Pathology biopsy report

211

516

2.06

18.41

1.8

1.5

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

4.84

18.37

1.0

2.66

3.06

u/ml

0.05

(21494890) Protein electrophoresis panel - 24 hour Urine

413

1255

1.66

18.31

2.2

1.9

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

103

3.61

18.25

1.0

1.2

1.11

11.56

u/ml

2.24

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

115

213

2.71

18.24

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

3.71

18.19

1.0

1.2

1.31

6.65

u/ml

1.56

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

587

1945

1.52

18.16

1.4

336.08

293.65

pmol/l

1.46

508

1681

(3034426) Prothrombin time (PT)

179

412

2.18

18.15

1.3

1.2

28.65

27.67

1.03

179

412

(4094501) Cardiovascular stress test using bicycle ergometer

1133

4246

1.35

17.89

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

177

409

2.17

17.79

3.1

2.3

0.61

mmol/l

0.28

177

409

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

356

1053

1.70

17.46

1.9

1.7

4.24

3.76

mg/l

0.98

346

999

(3033705) Calcium.ionized [Moles/volume] in Venous blood

477

1522

1.58

17.44

2.3

2.1

1.20

mmol/l

0.47

470

1507

(3001186) Copper [Moles/volume] in Serum or Plasma

152

332

2.30

17.40

1.4

1.2

16.74

16.43

umol/l

0.32

130

279

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

888

3222

1.39

17.16

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

888

3223

1.39

17.13

1.4

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

838

3021

1.40

16.83

1.1

3.58

4.16

u/ml

0.50

456

1401

(3012494) Peanut IgE Ab [Units/volume] in Serum

155

347

2.24

16.81

1.1

3.34

7.76

u/ml

0.78

206

(40757373) Influenza virus identified in Isolate

108

206

2.63

16.30

1.6

1.4

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

5.40

16.23

12.6

11.4

160.48

202.04

e6/l

0.25

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

334

992

1.69

16.19

1.5

1.3

13.30

12.51

u/l

1.12

319

966

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

260

717

1.82

16.18

1.2

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

183

446

2.06

16.18

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

723

2559

1.42

16.13

1.1

1.0

0.32

0.46

u/ml

0.55

269

622

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

186

457

2.05

16.11

1.7

1.8

177.96

169.22

0.40

176

426

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

350

1056

1.67

16.02

1.3

1.2

2.64

2.82

u/ml

0.08

215

483

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

106

3.36

15.96

1.2

1.3

53.96

54.43

0.02

(40768441) Liver Pathology biopsy report

345

1041

1.67

15.80

1.6

1.2

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

239

650

1.85

15.56

1.3

64.22

67.38

0.19

(3028679) Herpes simplex virus Ab [Presence] in Serum

302

884

1.72

15.45

1.2

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

403

1278

1.59

15.20

1.5

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

398

1261

1.59

15.07

5.0

5.7

56.94

82.10

u/ml

0.61

131

491

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

153

358

2.15

15.02

1.4

1.2

122.45

131.38

nmol/l

0.25

114

254

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

231

629

1.85

15.00

1.7

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

231

629

1.85

15.00

1.7

1.3

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

4.53

14.94

1.2

1.1

27.33

17.56

0.40

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

177

440

2.02

14.91

2.4

2.6

1.09

1.14

ug/l

0.09

166

416

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

145

2.87

14.68

1.7

7.58

479040.07

nmol/l

1.73

124

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

165

2.74

14.64

2.0

1.9

1.38

1.52

mmol/l

0.16

127

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

151

2.83

14.61

1.2

—

(3021901) Oxygen saturation in Capillary blood

907

3392

1.35

14.61

3.0

2.9

90.23

89.96

0.56

882

3301

(3008536) Aspergillus sp Ab [Presence] in Serum

103

205

2.52

14.39

2.4

2.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

266

768

1.74

14.31

1.2

98.09

89.76

u/l

0.47

223

653

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

135

306

2.22

14.31

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

135

306

2.22

14.31

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

135

306

2.22

14.31

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

135

306

2.22

14.31

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

7.27

14.24

3.3

1.5

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

253

721

1.76

14.23

8.4

4.8

10540.62

1539.67

u/ml

0.45

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1608

6510

1.25

14.20

1.7

1.6

5.10

3.93

mg/l

2.26

1223

4490

(3022493) Free Hemoglobin [Mass/volume] in Plasma

223

612

1.83

14.17

5.8

3.7

1082.12

4203.24

mg/l

1.33

164

415

(4015189) Microbial culture of sputum

105

213

2.48

14.14

2.5

2.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.84

13.99

1.0

1.2

0.10

1.38

u/ml

0.55

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1220

4793

1.28

13.85

1.8

1.6

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

15.05

13.75

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

167

420

2.00

13.68

1.9

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

285

852

1.68

13.59

1.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

823

3070

1.35

13.52

3.7

3.0

9.63

9.03

pmol/l

0.43

823

3065

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

282

842

1.68

13.51

1.4

1.2

5.40

5.63

umol/l

0.38

253

760

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

111

3.07

13.46

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1279

5077

1.27

13.38

1.2

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

177

2.58

13.33

2.2

1.6

49.10

53.26

pmol/l

0.12

153

(3016228) CD19 cells/cells in Blood

196

527

1.87

13.30

2.3

1.9

8.64

7.32

0.74

187

515

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

134

2.85

13.28

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

157

2.69

13.25

1.2

63.45

100.78

ng/l

0.55

106

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1468

9044

0.81

13.07

1.1

0.66

0.63

ratio

1.10

160

1054

(37021550) Renin [Units/volume] in Plasma --upright

185

2.52

13.06

1.4

1.3

56.38

64.28

mu/l

0.20

144

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

255

748

1.71

13.04

1.2

24.70

25.49

u/l

0.06

208

627

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

577

2046

1.42

12.86

1.7

1.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

244

710

1.73

12.85

1.1

24.15

22.40

u/l

0.18

222

615

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

625

2249

1.40

12.82

1.6

1.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

246

720

1.72

12.70

1.1

84.42

82.03

u/l

0.14

226

618

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

4.21

12.67

1.0

1.1

9.86

23.45

u/ml

0.59

(3002079) Sodium [Moles/time] in 24 hour Urine

223

636

1.76

12.58

1.3

1.2

168.12

167.55

mmol/24h

0.03

223

636

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

159

406

1.97

12.55

1.1

—

(3033099) Centromere Ab [Titer] in Serum

104

223

2.34

12.55

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

653

2377

1.38

12.53

1.1

3.42

2.74

eliau/ml

0.54

290

1338

(3011897) Casein IgE Ab [Units/volume] in Serum

101

214

2.37

12.50

1.2

1.4

5.57

2.62

u/ml

0.26

101

208

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

164

425

1.94

12.42

1.3

1.2

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

4.20

12.32

2.2

1.2

160.53

227.47

ug/g

1.10

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

128

303

2.12

12.31

2.1

1.5

41.86

33.29

u/l

0.19

122

274

(3017569) Oxygen content in Arterial blood

244

719

1.71

12.31

1.8

2.4

16.37

16.00

0.91

244

719

(3028717) Thiamine [Mass/volume] in Blood

155

2.62

12.27

1.3

1.1

66.83

63.80

ug/l

0.47

155

(3008116) Ketones [Moles/volume] in Urine by Test strip

125

294

2.14

12.22

1.6

1.2

0.21

0.35

mmol/l

0.74

(3036670) Protein [Mass/volume] in Synovial fluid

133

321

2.08

12.20

1.2

39.20

40.96

g/l

0.60

165

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

126

298

2.12

12.16

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

165

432

1.92

12.15

1.2

108.64

105.31

0.39

151

394

(3009015) Lactate [Moles/volume] in Synovial fluid

3.29

12.07

1.2

1.3

5.02

5.88

mmol/l

0.53

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

983

6275

0.78

12.01

1.7

1.6

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

105

231

2.28

12.00

1.6

1.5

0.35

0.42

ug/l

1.16

174

(3006576) Bicarbonate [Moles/volume] in Blood

166

439

1.90

11.89

6.8

5.5

24.83

24.99

mmol/l

0.21

156

385

(3034274) Bile acid [Moles/volume] in Serum --fasting

683

2527

1.36

11.89

2.4

2.2

8.08

6.17

umol/l

1.00

493

1853

(3020911) Cortisol [Moles/time] in 24 hour Urine

169

450

1.89

11.86

1.4

251.92

296.59

nmol/24h

0.09

169

450

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

163

430

1.90

11.76

1.1

92.44

91.40

0.14

201

(3038177) Helicobacter pylori Ab [Presence] in Serum

750

2823

1.34

11.68

1.2

1.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

194

544

1.79

11.62

2.3

1.9

30.20

32.08

0.87

194

544

(3051611) Lipemic interference index of Serum or Plasma

414

1406

1.48

11.61

3.7

3.2

13.26

13.24

index

0.01

252

774

(21491868) Cryoglobulin [Mass/volume] in Serum

177

483

1.84

11.55

1.3

1.2

0.23

0.22

g/l

0.03

(3033923) Metanephrine [Moles/time] in 24 hour Urine

188

2.40

11.51

1.1

0.71

0.96

umol/24h

0.33

(3001556) Androgen free Index in Serum or Plasma

117

2.83

11.49

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

143

2.63

11.47

1.1

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

3.42

11.38

1.5

1.7

2.44

2.57

mg/l

0.05

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.42

11.38

1.5

1.7

0.81

0.57

mg/l

0.27

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

3.42

11.38

1.5

1.7

0.79

1.38

mg/l

0.50

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

3.42

11.38

1.5

1.7

1.03

1.73

mg/l

0.51

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

3.42

11.38

1.5

1.7

4.50

3.42

mg/l

0.41

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.42

11.38

1.5

1.7

2.01

3.38

mg/l

0.64

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

3.42

11.38

1.5

1.7

2.20

1.80

mg/l

0.18

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

119

283

2.11

11.36

1.2

1.1

15.74

10.60

pmol/l

0.64

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

3.35

11.28

1.5

1.7

1.20

1.70

mg/l

0.35

(3051339) Copper [Moles/volume] in Blood

4.22

11.21

1.2

1.3

16.04

15.35

umol/l

0.32

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.37

11.17

1.5

1.7

1.75

1.07

mg/l

0.45

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

3.37

11.17

1.5

1.7

2.15

2.19

mg/l

0.01

(3036603) Volume of Urine

330

1078

1.54

11.12

1.7

1.6

2082.44

1964.11

1.31

325

1064

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

478

1684

1.43

11.11

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

137

2.64

11.07

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

765

2914

1.32

11.02

1.1

3.95

5.54

u/ml

1.49

377

1227

(43055514) Macroprolactin [Presence] in Serum or Plasma

143

371

1.94

10.87

1.4

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

3411

19292

0.88

10.87

1.6

3.44

3.51

mmol/l

2.60

2340

12967

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

4586

25475

0.89

10.86

1.9

3.56

3.53

ratio

0.58

3487

19348

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

107

2.86

10.83

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

248

762

1.64

10.79

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

4.28

10.79

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

219

651

1.69

10.79

2.2

2.5

162.94

172.01

ug/l

0.02

201

621

(3020491) Glucose [Moles/volume] in Blood

332

1095

1.52

10.73

1.7

1.9

6.25

6.73

mmol/l

2.64

228

886

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

122

2.72

10.71

1.1

1.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

100

227

2.21

10.70

1.2

234.58

324.35

pmol/l

1.95

176

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

351

1173

1.50

10.68

1.2

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

108

2.83

10.67

1.3

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

156

420

1.87

10.65

1.1

1.2

91.38

90.52

0.08

200

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

257

801

1.61

10.58

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

178

501

1.78

10.58

2.4

1.6

4876.36

2533.86

e6/l

0.23

129

297

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

2.96

10.52

1.0

1.1

8.48

8.04

u/ml

0.04

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

216

2.23

10.49

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

124

2.67

10.41

1.1

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

788

3043

1.30

10.32

1.5

1.4

0.35

0.42

nmol/l

1.40

611

2392

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

290

937

1.56

10.30

1.1

1.2

1.06

1.07

ratio

0.42

243

760

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

189

2.31

10.29

1.1

—

(3018133) Calcium [Moles/volume] in Urine

228

2.18

10.26

2.1

1.6

2.61

2.78

mmol/l

0.31

212

(3045462) Protein/Creatinine [Ratio] in Urine

165

2.40

10.17

3.8

6.4

49.44

49.47

mg/mmol

0.00

154

(3007463) Buprenorphine [Presence] in Urine

3.87

10.14

6.0

12.1

—

(3009871) Measles virus Ab [Titer] in Serum

194

568

1.72

10.12

1.7

1.6

3505.88

3407.40

titre

0.05

100

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.99

9.97

3.5

1.3

—

(44813793) Dust mix specific IgE antibody measurement

322

1074

1.51

9.93

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

226

694

1.64

9.90

1.7

3.00

u/field

0.00

162

556

(3010015) Selenium [Moles/volume] in Serum or Plasma

119

2.66

9.87

2.3

1.5

1.29

1.31

umol/l

0.16

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

229

2.15

9.84

1.2

1.1

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

102

2.80

9.82

1.0

1.1

2.19

1.88

u/ml

0.07

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.84

9.80

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

224

690

1.63

9.71

1.1

1.2

18.23

19.92

u/ml

0.04

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

190

560

1.70

9.71

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

282

919

1.54

9.68

1.7

1.8

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

101

241

2.10

9.64

1.3

23.06

22.96

0.01

198

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

133

2.53

9.57

1.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

491

1788

1.38

9.54

1.6

1.5

59.34

56.89

0.62

310

1106

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.02

9.46

4.5

5.0

—

(3021788) Differential panel - Synovial fluid

763

2970

1.29

9.46

1.6

1.5

1.00

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3.00

9.45

1.3

1.2

15.78

14.30

nmol/l

0.19

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

2.79

9.40

1.4

12.01

20.87

pmol/l

0.87

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

190

567

1.68

9.30

2.3

1.9

8.78

9.49

mg/l

1.00

164

446

(37208534) Antinuclear antibody arbitrary concentration in serum

153

429

1.79

9.28

1.1

—

(3004775) Volume in Urine collected for unspecified duration

322

1094

1.48

9.13

2.4

2.0

625.52

697.52

2.45

227

677

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.04

9.06

1.3

1.1

0.59

0.40

iu/ml

0.27

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1821

7807

1.18

9.03

3.1

3.5

47.63

57.35

u/ml

1.07

1764

7581

(3023199) Leukocytes [#/volume] in Pleural fluid

495

1824

1.36

8.98

1.5

1.4

2585.37

2966.58

e6/l

0.24

368

1223

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

125

332

1.89

8.98

1.2

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

109

276

1.98

8.96

2.5

2.9

299.28

908.43

ug/l

0.58

109

276

(3001686) Cold agglutinin [Titer] in Serum or Plasma

205

2.15

8.94

1.4

1.2

64.40

555.52

titre

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

496

1831

1.36

8.90

2.0

1.9

21.22

27.97

ug/l

2.74

491

1806

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

202

622

1.63

8.82

1.9

2.2

101.98

135.35

ug/min

0.23

118

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

157

451

1.75

8.82

2.8

2.9

28.62

28.27

umol/l

0.13

107

346

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

134

2.43

8.66

1.0

1.1

0.75

0.54

u/ml

0.17

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

131

2.45

8.65

1.1

—

(3005033) Fetal Nuchal fold Thickness US

878

5458

0.80

8.64

1.5

1.24

1.26

0.39

637

3969

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

141

2.38

8.56

1.6

1.7

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.92

8.54

1.5

1.6

48.22

44.86

umol/l

0.24

(3047352) Trisomy 18 risk [Likelihood] in Fetus

898

5557

0.81

8.47

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

133

369

1.81

8.40

1.6

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

790

4949

0.80

8.35

1.6

1.5

58.61

61.03

ug/l

0.86

790

4949

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

247

810

1.53

8.32

6.7

8.0

154.76

36.30

ug/l

0.66

149

567

(3043238) Trisomy 21 risk [Likelihood] in Fetus

919

5662

0.81

8.32

1.6

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

389

1396

1.40

8.31

1.4

1.3

369.99

482.41

u/l

1.29

369

1326

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

244

799

1.53

8.28

1.5

6.70

6.32

u/l

0.16

197

588

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.89

8.24

1.1

1.0

—

(3022229) Phosphate [Moles/volume] in Urine

3.26

8.13

2.4

1.6

17.02

21.90

mmol/l

0.77

(3036180) Methadone [Presence] in Urine

5.96

8.07

2.8

1.6

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

171

518

1.66

8.00

1.4

1.5

74.40

72.87

0.75

166

498

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

178

545

1.64

8.00

3.0

2.4

103.20

143.83

au/ml

0.52

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

479

1791

1.34

7.98

1.1

—

(44806071) Cardiolipin IgM antibody measurement

169

2.20

7.93

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

210

2.06

7.84

1.7

1.3

0.23

0.24

nmol/l

0.11

137

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.61

7.83

1.3

1.1

1.43

1.66

iu/ml

0.38

(3043410) Blood group antigens tested for on Red Blood Cells

132

374

1.77

7.82

1.5

1.7

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

167

506

1.66

7.82

1.4

1.5

406.50

861.96

mu/l

1.30

162

486

(3014891) Appearance of Pleural fluid

154

2.25

7.80

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

336

1189

1.42

7.80

1.1

8.00

8.13

iu/ml

0.04

391

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

209

672

1.56

7.72

1.2

1.3

1083.78

1075.17

titre

0.03

149

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

194

614

1.59

7.66

3.7

3.1

1.29

1.25

0.11

194

614

(3003434) Protein [Mass/volume] in Pleural fluid

549

2108

1.31

7.64

1.6

1.4

32.10

33.50

g/l

1.73

495

1924

(3002331) Protein [Mass/volume] in Peritoneal fluid

117

322

1.82

7.62

1.3

1.2

24.06

99.95

g/l

0.74

252

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.17

7.62

1.8

2.0

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

219

715

1.54

7.58

1.2

1.1

3.50

4.28

iu/ml

0.50

(3024869) Neuronal Ab [Presence] in Serum

194

2.07

7.45

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

848

3447

1.24

7.44

1.7

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1008

4178

1.21

7.34

2.3

131.10

131.26

g/l

0.07

768

3383

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

133

2.30

7.29

1.0

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

156

2.19

7.25

1.3

1.2

475.95

67.59

u/l

0.50

110

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

3.06

7.25

1.1

26.75

20.23

u/ml

0.26

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

3.06

7.25

1.1

31.24

14.18

u/ml

1.17

(3016750) Collection duration of Urine

243

820

1.49

7.24

2.3

2.0

495.47

502.00

min

0.45

193

549

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

119

335

1.78

7.24

1.3

30.81

40.37

1.89

235

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

149

448

1.67

7.22

1.2

1.3

23.33

22.60

0.04

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4.27

7.15

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

147

442

1.67

7.13

1.2

1.3

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

194

626

1.56

7.10

3.9

3.2

7.86

9.29

mg/l

2.32

156

482

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

198

644

1.54

7.01

1.1

96.64

95.11

0.26

159

494

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

4.78

6.98

2.0

1.7

158.92

190.63

nmol/l

0.28

(3013727) Leukocytes other/Leukocytes in Blood

141

422

1.68

6.97

3.9

3.3

54.31

52.45

0.38

136

407

(3026692) Albumin [Mass/volume] in Peritoneal fluid

128

374

1.72

6.90

1.5

1.2

12.68

13.26

g/l

0.27

282

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.80

6.80

2.7

2.1

0.67

0.61

ug/l

0.43

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

106

294

1.81

6.79

1.2

70.75

75.54

0.32

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

237

808

1.47

6.76

1.4

5.63

5.54

mmol/l

0.51

224

763

(3047189) Immunofixation for 24 hour Urine

184

596

1.55

6.66

1.8

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

104

2.41

6.64

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

594

2356

1.27

6.52

1.3

6.98

6.94

mmol/l

0.10

528

2096

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

146

450

1.63

6.49

2.1

1.5

18465.57

12882.30

e6/l

0.17

198

(3038071) Oxygen [Partial pressure] in Mixed venous blood

105

296

1.78

6.42

7.0

5.4

5.27

kpa

0.01

105

296

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.43

6.35

1.1

—

(3044007) Cell count panel - Peritoneal fluid

149

466

1.61

6.27

2.2

1.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3000

13637

1.11

6.27

4.1

3.8

1.23

1.22

mmol/l

0.62

2670

11412

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

2.78

6.24

1.1

1.75

4.43

u/l

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

937

3925

1.20

6.19

1.2

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

216

1.91

6.18

7.3

6.1

10.66

10.73

0.11

216

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.05

6.17

4.3

3.3

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

154

2.09

6.15

3.4

2.9

37.55

46.07

umol/l

1.88

134

(3013336) Amino acids [Identifier] in Serum or Plasma

4.18

6.09

3.5

2.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

162

2.04

6.04

2.1

1.5

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

136

420

1.63

6.04

1.8

1.7

147.70

133.87

au/ml

0.11

(3036071) Salmonella sp Ab [Titer] in Serum

158

508

1.56

5.96

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

163

2.03

5.95

1.2

1.3

36.27

47.72

mg/l

1.06

136

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

322

1189

1.36

5.95

2.0

1.9

1.74

1.66

u/field

0.11

191

629

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

108

315

1.72

5.92

1.2

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

107

2.30

5.92

1.3

706.74

87.51

mg/24h

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

209

1.90

5.90

1.7

1.3

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

250

1.81

5.81

2.8

3.0

1635.84

1665.91

u/l

0.01

226

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

151

2.06

5.80

1.0

0.02

0.42

u/ml

0.96

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.54

5.78

1.1

1.0

—

(44806420) Estimation of glomerular filtration rate

383

2494

0.77

5.75

2.5

2.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.82

5.70

3.7

4.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

103

300

1.72

5.70

1.2

78.00

84.02

0.59

(4133840) Spirometry

139

439

1.59

5.67

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

202

693

1.46

5.67

4.5

3.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

428

1662

1.29

5.62

1.5

1.4

64011.00

49271.65

e6/l

0.40

260

889

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

115

348

1.66

5.56

6.8

5.8

5.89

6.09

kpa

1.72

106

296

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

811

3390

1.20

5.54

1.5

1.4

146.25

144.54

pmol/l

0.02

795

3321

(3016031) Almond IgE Ab [Units/volume] in Serum

101

2.29

5.51

1.0

1.1

1.14

1.29

u/ml

0.09

(3027231) Wheat IgE Ab [Units/volume] in Serum

289

1.72

5.45

1.1

4.11

0.77

u/ml

0.67

275

(40760410) HLA-B [Type] by High resolution

3.39

5.44

1.0

—

(40760409) HLA-A [Type] by High resolution

3.39

5.44

1.0

—

(46236302) HLA-C [Type] by High resolution typing

3.39

5.44

1.0

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.84

5.43

1.3

1.2

0.08

g/l

0.03

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

146

472

1.55

5.42

2.1

1.9

1.75

1.69

ratio

0.16

137

459

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

152

497

1.54

5.38

3.3

2.2

4.82

4.93

kpa

0.52

152

497

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

152

497

1.54

5.38

3.3

2.2

10.61

10.38

kpa

0.41

152

497

(3002621) Streptococcal DNAse B [Units/volume] in Serum

122

2.14

5.37

1.1

313.78

322.03

u/ml

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

231

823

1.41

5.33

1.8

1.83

3.52

u/ml

1.42

246

(3012920) Ethanol [Mass/volume] in Serum or Plasma

6.27

5.33

1.5

1.1

2.21

1.48

g/l

0.87

(40763590) HLA-DQ beta [Type]

3.45

5.33

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

593

3632

0.82

5.25

1.3

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.03

5.24

7.9

8.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

301

1124

1.35

5.24

1.3

1.2

13.97

14.16

u/l

0.04

276

1053

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.58

5.23

3.5

3.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

144

2.02

5.21

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.17

5.17

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2204

12231

0.90

5.15

1.6

1028.31

1018.16

mu/l

0.16

1881

10377

(3013862) HLA-DP [Type]

3.34

5.12

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

125

2.09

5.08

2.6

3.0

0.60

0.48

u/field

0.36

125

(3020650) Glucose [Presence] in Urine

112

875

0.64

5.01

1.7

1.4

0.03

0.04

estimate

0.22

112

875

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.51

4.96

1.1

—

(3045788) Cell count panel - Pleural fluid

394

1543

1.28

4.92

1.5

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

552

2250

1.23

4.90

1.7

1.4

—

(3029612) Listeria sp Ab [Titer] in Serum

4.43

4.88

1.3

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

141

1.99

4.87

1.3

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

145

1.97

4.83

1.5

—

(3019174) dRVVT (LA screen)

2.20

4.79

1.2

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

334

1285

1.31

4.78

1.1

18.81

20.54

u/ml

0.28

136

562

(3032352) Blasts [#/volume] in Cerebral spinal fluid

132

2.01

4.76

3.4

1.9

—

(3026470) Cobalt [Mass/volume] in Blood

212

762

1.40

4.71

2.2

2.3

2.71

3.52

ug/l

1.52

198

709

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

222

805

1.38

4.69

1.2

1.1

175.52

227.74

iu/ml

1.78

222

795

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

126

2.03

4.68

1.0

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

361

1409

1.29

4.65

1.8

1.7

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

296

1.64

4.62

1.3

1.2

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

2.85

4.60

1.1

1.0

8.00

8.77

mmol/l

1.23

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

846

3618

1.18

4.55

1.7

1.6

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

128

2.00

4.51

1.3

1.2

0.97

0.34

u/ml

—

(3002523) Influenza virus A Ag [Presence] in Specimen

908

3916

1.17

4.41

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

102

2.11

4.39

1.5

1.4

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

2.29

4.39

1.2

1.3

0.89

1.31

ml/s/173m2

1.73

(3013247) Albumin in CSF/Albumin in Serum or Plasma

106

336

1.58

4.37

1.1

6.67

6.34

mg/g

0.18

101

324

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

325

1264

1.29

4.34

1.2

1.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.36

4.33

1.7

1.6

36.40

19.39

nmol/l

0.62

(40762887) Creatinine [Moles/volume] in Blood

2.40

4.31

1.6

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

906

3915

1.16

4.30

1.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.73

4.29

1.0

1.1

0.56

0.42

umol/24h

0.13

(3033086) Enterovirus Ab [Titer] in Serum

3.13

4.28

1.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.10

4.13

1.1

1.2

1.79

1.69

umol/24h

0.25

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.17

4.13

1.3

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

165

1.82

4.12

2.7

2.6

69.11

73.58

pmol/l

0.09

148

(4211845) Urine protein measurement

201

736

1.37

4.07

3.6

2.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

159

559

1.43

4.06

1.2

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.02

4.05

6.4

1.5

—

(3017509) Phencyclidine [Presence] in Urine

196

1.74

4.02

1.6

1.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

164

1.80

3.94

1.3

1.2

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

2.19

3.93

1.0

1.1

0.70

4.09

u/ml

1.44

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

2.35

3.92

1.2

1.4

40.88

35.44

0.20

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

139

1.88

3.91

1.7

1.6

—

(3036782) Glucose [Moles/volume] in Pleural fluid

396

1602

1.24

3.87

1.5

1.3

6.26

6.06

mmol/l

0.67

367

1494

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

218

1.68

3.84

1.0

81.06

77.76

ug/l

0.29

177

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

3.11

3.83

1.1

1.0

—

(3013762) Body weight Measured

2.98

3.79

1.2

—

(3025577) Chromium [Mass/volume] in Blood

203

755

1.35

3.76

2.2

2.3

1.99

2.30

ug/l

0.78

170

649

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.77

3.73

2.1

2.4

284.33

211.53

ug/l

0.70

(3018001) Oat IgE Ab [Units/volume] in Serum

2.14

3.73

1.0

0.19

0.29

u/ml

0.26

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

115

387

1.49

3.71

1.2

315.48

180.60

ug/l

0.21

201

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.01

3.65

1.2

1.6

30.19

30.93

umol/24h

0.04

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

3.42

3.64

7.0

4.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.12

3.63

1.5

1.4

—

14.32

—

(40762814) Titanium [Mass/volume] in Blood

177

1.73

3.57

2.4

2.6

4.05

3.54

ug/l

0.22

(3017315) Amylase [Enzymatic activity/volume] in Urine

227

867

1.31

3.55

1.3

1.2

317.37

368.49

u/l

0.28

209

817

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.71

3.44

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

314

1259

1.25

3.38

1.1

2.39

2.09

u/ml

0.09

116

349

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.94

3.34

1.0

2.40

1.17

u/ml

0.39

(3000285) Sodium [Moles/volume] in Blood

239

1.60

3.33

1.2

139.14

138.67

mmol/l

0.48

203

(3042951) Complement C1q Ab [Units/volume] in Serum

2.41

3.33

1.1

1.2

25.75

26.53

u/ml

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

311

1.52

3.32

1.3

1.2

175.82

54.82

mg/l

0.81

218

(3014599) Egg white IgE Ab [Units/volume] in Serum

310

1244

1.25

3.32

1.1

3.07

5.13

u/ml

0.24

284

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

174

1.70

3.30

2.0

1.7

1.57

1.80

mg/l

0.54

143

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.64

3.29

1.1

1.0

—

(3042631) Mycobacterium sp identified in Specimen

501

2115

1.19

3.26

3.1

2.4

—

(3006462) Nitrate [Presence] in Urine

179

672

1.34

3.19

3.8

2.5

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

302

1.51

3.19

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

2.04

3.18

1.0

1.13

0.24

u/ml

0.39

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

2.25

3.14

1.2

1.4

14.87

15.21

0.02

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

304

1.50

3.10

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

304

1.50

3.10

1.1

—

(3012441) Differential panel - Pleural fluid

405

1686

1.21

3.09

1.6

1.4

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.97

3.09

1.3

1.7

10.59

9.94

u/ml

0.02

(3044009) aPTT.lupus sensitive (LA screen)

114

1.85

3.09

1.3

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.94

3.05

1.5

1.3

312.69

324.49

umol/24h

0.17

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.51

3.02

1.6

1.4

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.58

3.01

1.2

1.0

255.09

214.29

pmol/l

0.13

(40758292) HTLV I+II Ab panel - Serum

311

1.48

2.98

1.4

1.3

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

101

1.89

2.98

1.2

1.1

10.42

12.00

u/l

0.19

101

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

340

1.46

2.97

1.2

69.02

67.33

ug/l

0.11

340

(3027696) Helicobacter pylori Ab [Titer] in Serum

5.73

2.91

1.1

1.0

1466.25

1378.57

titre

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.89

2.90

1.2

1.1

3.53

2.58

0.63

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

2.03

2.89

2.1

2.9

2.07

68.33

pmol/l

—

(3050794) Legionella sp Ab [Presence] in Serum

132

1.75

2.87

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

110

1.82

2.85

1.3

1.2

43.21

48.81

mg/l

0.54

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

136

1.73

2.85

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

182

1.63

2.85

1.5

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

114

406

1.41

2.84

1.3

57.83

56.46

0.14

349

(3035880) pH of Pleural fluid

213

835

1.28

2.83

1.4

1.2

7.41

7.40

0.38

160

551

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

142

526

1.35

2.81

1.1

4.71

8.57

u/ml

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.10

2.79

1.5

2.7

4.09

1.79

mu/l

0.66

(3002619) Bacteria identified in Specimen by Culture

109

387

1.41

2.78

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3607

19103

0.94

2.77

3.6

3.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

284

1.48

2.75

1.3

1.2

1.59

1.66

mmol/l

0.15

167

(3049233) Organic acids panel - Urine

4.51

2.74

1.1

1.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

248

1.52

2.73

1.4

2.0

1.75

4.41

ug/l

0.86

168

(3052592) Norovirus Ag [Presence] in Stool

233

1.53

2.68

1.5

1.3

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

5.02

2.67

1.0

0.03

0.17

u/ml

—

(3015350) Toxocara sp Ab [Presence] in Serum

3.17

2.66

1.0

1.1

—

(3022670) pH of Venous cord blood

2.33

2.65

1.1

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.92

2.59

1.2

1.3

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

219

1.53

2.58

1.5

1.6

133.56

112.76

ug/l

0.72

178

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

152

1.65

2.58

1.5

1.4

73.50

69.56

0.41

124

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.24

2.56

1.1

0.04

2.28

u/ml

1.39

(3000012) Reticulocyte production index

562

2452

1.15

2.53

2.1

2.2

0.91

0.90

0.25

385

1627

(3020618) Glucose [Moles/volume] in Synovial fluid

2.32

2.51

1.1

5.61

4.88

mmol/l

0.40

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

138

1.67

2.50

4.7

2.5

1.06

1.31

mg/l

0.58

(3042010) Triglyceride [Moles/volume] in Pleural fluid

222

1.51

2.45

1.3

1.2

2.05

1.27

mmol/l

0.35

137

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.51

2.45

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

2.70

2.44

1.4

1.2

1.67

2.35

mmol/24h

0.78

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.91

2.42

1.1

1.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

5.02

2.39

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

125

1.69

2.37

1.1

105.14

91.39

titre

0.34

125

(40765089) Chromosome analysis panel - Blood by G-banded

181

714

1.27

2.36

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

326

1370

1.19

2.35

2.8

2.2

30.09

28.58

mg/l

0.26

230

972

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

2.15

2.35

1.0

1.1

—

(3008343) Lysozyme [Mass/volume] in Urine

6.02

2.34

1.0

0.43

27.20

mg/l

—

(40759632) Porphyrins [Mass/mass] in Stool

6.02

2.34

1.2

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

6.02

2.34

1.0

236.67

281.60

nmol/l

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.93

2.33

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

755

4232

0.89

2.33

3.6

3.0

26.78

27.98

mg/l

0.37

506

2957

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

2.43

2.32

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.80

2.31

1.8

1.5

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.83

2.29

1.3

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.11

2.25

1.6

1.3

—

(3007700) Barley IgE Ab [Units/volume] in Serum

1.96

2.24

1.0

1.71

0.16

u/ml

0.74

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

284

1701

0.84

2.23

1.5

1.6

—

(40768806) Pleura Pathology biopsy report

396

1702

1.17

2.22

1.6

1.5

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

3.47

2.22

1.1

1.26

1.38

mg/l

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

3.13

2.19

1.3

1.1

—

(3024316) Viscosity of Plasma

1.88

2.17

1.7

2.0

1.60

1.97

mpas

1.07

(3007919) Fasciola sp Ab [Titer] in Serum

2.61

2.15

1.0

1.1

—

(3041184) Isoniazid [Presence] in Urine

3.65

2.11

2.8

2.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

532

2348

1.14

2.09

1.3

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

177

709

1.25

2.08

1.1

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

2.03

2.07

1.1

0.03

0.97

mg/l

0.52

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

165

656

1.26

2.07

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

371

1599

1.16

2.04

1.4

1.3

195.58

200.39

pmol/l

0.06

371

1599

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

355

1.36

2.03

1.4

1.2

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

120

1.63

1.99

1.3

1.2

136.56

106.26

ug/l

0.37

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

1.99

1.98

1.1

1.3

0.40

0.94

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.75

1.96

1.7

1.5

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.73

1.95

1.1

1.2

—

(3007456) Orange IgE Ab [Units/volume] in Serum

2.28

1.94

1.0

0.18

0.08

u/ml

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.84

1.93

1.4

1.1

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

2.13

1.90

5.0

5.4

0.91

1.63

mg/l

1.02

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

162

1.52

1.88

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

162

1.52

1.88

2.4

2.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

277

1175

1.18

1.88

1.0

1.1

1.46

0.77

u/ml

0.31

229

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

103

1.66

1.86

6.1

5.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1160

6288

0.92

1.85

1.5

0.94

ratio

0.04

718

3623

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1160

6288

0.92

1.85

1.5

1.19

1.18

ratio

0.12

724

3644

(3017958) Strawberry IgE Ab [Units/volume] in Serum

2.21

1.83

1.1

1.0

0.01

0.06

u/ml

—

(3023383) Lactate [Moles/volume] in Pleural fluid

112

432

1.30

1.82

1.4

1.2

3.69

3.73

mmol/l

0.03

105

399

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

2.08

1.81

1.1

1.0

13.42

15.91

mg/l

0.11

(3034614) HLA Ag [Interpretation]

2.26

1.80

1.4

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

358

1557

1.15

1.79

1.6

7.79

7.52

mmol/l

1.37

339

1503

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1142

6181

0.92

1.77

1.4

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1160

6269

0.93

1.74

1.5

1.13

1.18

ratio

0.83

718

3604

(3004451) EKG impression Narrative

225

946

1.19

1.72

1.3

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.65

1.71

2.4

1.5

—

(3012501) Base excess in Blood by calculation

783

4294

0.91

1.68

4.3

3.7

2.38

2.49

mmol/l

0.56

529

2882

(3013290) Carbon dioxide [Partial pressure] in Blood

784

4294

0.91

1.64

4.3

3.7

5.03

5.00

kpa

0.54

767

4196

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

107

1.59

1.64

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

115

1.57

1.64

1.0

—

(3027315) Oxygen [Partial pressure] in Blood

787

4304

0.92

1.60

4.4

3.7

8.72

8.64

kpa

0.55

769

4206

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

253

1.37

1.60

1.4

1.2

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

136

549

1.24

1.58

1.6

1.4

63.33

63.47

0.01

107

467

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

3.34

1.57

1.2

1.0

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

195

1.41

1.55

1.5

—

(4212803) Bone marrow aspirate examination

122

1.52

1.49

1.1

1.0

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

2.51

1.48

1.0

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.39

1.44

2.2

2.1

24.62

25.90

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

2.39

1.44

1.0

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

2.39

1.44

1.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

514

2330

1.11

1.40

3.9

3.6

23.91

43.61

u/ml

5.24

499

2243

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

100

1.55

1.39

1.0

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

1.85

1.38

1.0

0.11

0.06

u/ml

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

282

1.32

1.38

3.0

2.6

40.87

33.65

mg/l

0.16

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

154

1.43

1.36

1.2

1.1

21.38

20.73

u/l

0.05

102

(3027305) Fractional oxyhemoglobin in Arterial cord blood

2.28

1.33

1.1

37.92

33.36

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

342

1521

1.13

1.32

1.5

27.50

32.18

1.50

208

938

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.61

1.29

1.0

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

1.59

1.29

1.1

48.60

48.19

u/l

0.01

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

143

0.60

1.27

1.7

1.9

16.50

19.33

0.14

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

389

1749

1.12

1.27

1.4

9.04

7.94

mmol/l

4.94

369

1668

(3020093) Fractional oxyhemoglobin in Venous cord blood

2.12

1.26

1.2

1.1

72.92

63.69

0.78

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.62

1.24

5.8

3.4

103.48

105.28

g/l

0.25

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

550

3010

0.92

1.22

2.5

2.3

13.17

13.12

0.61

545

2966

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

2.79

1.17

1.0

3.3

—

(40768800) Prostate Pathology biopsy report

734

3417

1.08

1.16

1.2

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

242

1.31

1.16

1.7

1.4

9.41

10.56

0.20

141

(3001218) Citrate [Mass/time] in 24 hour Urine

1.94

1.13

1.5

1.4

427.42

408.19

mg/24h

0.09

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.34

1.11

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.34

1.11

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.34

1.11

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.34

1.11

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.34

1.11

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.34

1.11

2.0

—

(1616796) Gas panel - Central venous blood

897

4216

1.07

1.10

3.9

3.6

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.86

1.10

9.4

10.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

2.51

1.05

1.0

1.1

1.25

1.50

u/ml

—

(3032641) Amino acids panel - Urine

2.19

1.05

1.6

1.2

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

211

927

1.14

1.05

1.2

9.33

9.83

mm/h

0.27

211

927

(46235168) Fasting glucose [Moles/volume] in Blood

255

1.28

1.05

1.5

2.1

8.33

7.04

mmol/l

1.11

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

1.90

0.99

1.0

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

2.06

0.99

1.1

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

121

714

0.85

0.97

3.2

3.4

44.43

45.28

0.16

121

714

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

121

714

0.85

0.97

6.4

6.7

9.30

8.54

0.69

121

714

(3002814) Trichinella spiralis Ab [Titer] in Serum

2.11

0.94

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1296

6194

1.05

0.94

1.5

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

257

1.25

0.89

5.8

5.3

42.65

47.36

ug/min

0.24

207

(40758358) Immune stain study

1.67

0.88

1.0

—

(3035715) Granulocytes [#/volume] in Blood

711

3790

0.94

0.86

3.7

3.2

4.05

4.16

e9/l

0.65

711

3784

(40761539) Cells [Type] in Urine sediment by Light microscopy

382

1.19

0.85

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

378

1.19

0.83

3.4

2.4

146.56

100.10

ng/l

0.53

186

(3040151) Glucose [Moles/volume] in Capillary blood

466

2168

1.08

0.83

20.8

5.7

7.63

7.09

mmol/l

1.88

382

1801

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1256

6584

0.96

0.83

1.5

1.6

59.92

62.70

ug/l

1.26

1060

5421

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

162

0.71

0.82

1.8

2.1

59.18

58.52

0.03

101

(44786800) Granulocytes/Leukocytes in Body fluid

185

1.27

0.79

1.3

1.4

34.57

24.09

0.89

141

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.49

0.78

1.6

1.4

723.94

433.01

nmol/l

0.89

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.55

0.76

1.2

1.0

177.33

165.64

g/l

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

268

1.22

0.75

1.0

1.1

6.24

8.63

u/ml

0.31

268

(3022806) Fractional oxyhemoglobin in Capillary blood

434

2336

0.93

0.74

2.0

1.7

90.09

89.63

1.01

428

2299

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.54

0.71

1.1

200.41

270.84

nmol/l

0.91

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.76

0.71

1.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

170

951

0.90

0.70

1.6

1.4

0.51

e9/l

0.12

170

951

(40768793) Breast Pathology biopsy report

779

3718

1.05

0.67

1.3

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.64

0.0

1.1

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.64

0.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.67

0.64

1.0

—

(3011544) Albumin [Mass/volume] in Pleural fluid

197

0.79

0.60

1.1

1.2

17.68

17.88

g/l

0.04

180

(3051101) Glucose [Moles/volume] in Cord blood

294

0.84

0.56

6.0

8.04

8.39

mmol/l

0.42

294

(4038314) Semen analysis, post vasectomy

181

1.22

0.56

1.2

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

100

1.30

0.56

6.7

2.1

6.54

16.86

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

1.46

0.56

1.1

1.0

0.19

0.07

u/ml

—

(3028271) Lactate [Moles/volume] in Capillary blood

578

3047

0.95

0.56

2.0

1.7

1.69

1.78

mmol/l

1.31

563

2967

(3016273) Islet cell 512 Ab [Units/volume] in Serum

136

1.25

0.55

1.0

—

(40768795) Lymph node Pathology biopsy report

372

1765

1.06

0.46

1.2

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.36

0.46

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

788

4098

0.96

0.45

2.8

2.5

16.69

16.62

0.24

773

4010

(3046861) Legionella sp Ag [Presence] in Urine

145

0.80

0.45

1.0

1.1

—

(3015531) Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma

0.00

0.43

0.0

1.1

—

5.50

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.72

0.43

1.0

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.43

0.0

1.1

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.43

0.0

1.2

—

1.81

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.43

0.0

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

1.47

0.42

7.5

6.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.36

0.38

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

218

1.15

0.38

1.2

1.3

5.61

5.83

mmol/l

0.97

218

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.50

0.37

1.0

1.1

2951.00

3845.45

titre

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

414

1.10

0.36

1.0

1.1

42.39

30.26

iu/ml

1.06

414

(3050129) First trimester maternal screen panel - Serum or Plasma

1515

7431

1.02

0.36

1.5

1.4

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.43

0.36

1.2

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.78

0.35

1.3

1.2

4377.11

3186.41

ng/l

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

247

1174

1.06

0.33

2.1

1.7

308.71

881.02

pmol/l

0.45

147

(3003577) Lead [Moles/volume] in Blood

174

1.15

0.33

1.3

1.6

0.12

0.40

umol/l

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.25

0.33

1.1

1.2

—

(4281824) Cell count and differential, peritoneal fluid

356

1863

0.96

0.32

1.2

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

2067

10191

1.02

0.32

1.7

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

218

1154

0.95

0.31

1.6

1.4

—

(3001729) Color of Synovial fluid

128

1.18

0.31

1.5

1.6

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.34

0.29

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.31

0.29

1.3

1.0

—

mmol/l

—

(3018291) Platelet Ab [Presence] in Serum

1.25

0.28

1.0

1.1

—

(3040794) Aluminum [Moles/volume] in Urine

1.29

0.27

1.1

1.3

0.23

0.38

umol/l

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.29

0.27

6.9

5.9

0.32

0.21

mmol/l

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.22

0.26

1.1

1.0

308.56

246.83

u/ml

—

(3009677) Dengue virus Ab [Presence] in Serum

1.22

0.25

1.1

—

(3025130) Human papilloma virus identified in Specimen

573

2953

0.97

0.25

1.9

1.8

—

(3022475) Manganese [Moles/volume] in Blood

1.17

0.24

1.4

1.2

0.17

0.15

umol/l

0.73

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

218

1.10

0.23

1.2

20.19

20.54

mmol/l

0.18

180

(3010421) pH of Blood

1233

6079

1.02

0.23

4.0

3.4

7.41

4.42

1217

5991

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

255

1231

1.04

0.22

1.5

1.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

109

1.15

0.22

1.0

1.1

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.1

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.1

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.1

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

114

1.14

0.21

1.5

1.7

0.64

0.00

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

227

1179

0.97

0.19

1.6

1.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

134

641

1.05

0.18

3.0

3.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

209

0.91

0.18

2.7

2.5

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.23

0.17

1.2

1.3

32.06

33.04

mg/24h

0.06

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

193

1.09

0.17

1.1

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

247

1.08

0.16

1.1

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

248

1279

0.97

0.15

1.5

1.4

42.50

34.39

nmol/l

0.69

224

1199

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

147

1.09

0.14

1.1

1.35

1.17

mom

0.57

147

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.87

0.14

1.1

1.0

—

(3034891) Synovial lining cells/cells in Synovial fluid

169

823

1.03

0.12

1.5

1.4

3.24

4.54

0.52

204

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

335

0.96

0.09

2.0

2.7

7.90

7.24

mmol/l

0.47

169

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

301

1535

0.98

0.09

1.6

1.4

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.07

0.09

1.2

1.0

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.06

0.07

1.1

1.2

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

142

1.06

0.07

1.1

1.0

3.16

3.70

kpa

0.72

120

(3004959) Base excess in Arterial cord blood by calculation

142

1.06

0.07

1.1

1.0

-2.87

-1.50

mmol/l

—

(3010937) Rubella virus Ab [Presence] in Serum

133

1.06

0.06

1.1

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

106

520

1.02

0.06

1.6

1.4

2.19

2.39

0.09

446

(3000919) Neutrophils/Leukocytes in Pleural fluid

451

1.02

0.05

1.6

1.4

23.59

22.02

0.20

411

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

621

3092

1.01

0.05

1.5

1.3

4.00

3.98

ug/l

0.01

562

2824

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.94

0.04

1.1

1.5

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

136

0.96

0.03

1.0

1.1

8.33

17.20

iu/ml

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

145

1.04

0.03

1.1

1.0

7.29

7.34

kpa

0.06

124

(3006598) pH of Arterial cord blood

145

1.04

0.03

1.1

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

226

1137

1.00

0.00

1.1

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

259

0.99

0.00

1.1

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.99

0.00

1.0

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

121

0.99

0.00

1.0

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.95

0.00

1.0

1.1

0.22

0.09

g/l

—

(3035082) Kappa light chains [Mass/volume] in Urine

1.00

0.00

1.1

0.02

0.25

g/l

—

(42870560) Thyrotropin [Units/volume] in Cord blood

144

1.01

0.00

1.0

12.31

9.03

mu/l

1.20

112

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

266

1334

1.00

0.00

1.2

1.3

—

(3012565) Volume of 24 hour Urine

185

929

1.00

0.00

2.3

2.2

1962.73

2010.04

0.25

166

851

(3003195) risperiDONE [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

3.92

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

-0.00

0.0

2.8

—

3.40

—

(3035963) Corticotropin [Moles/volume] in Plasma

0.00

-0.00

0.0

1.0

—

10.68

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES – Persons encountering health services for examination and investigation

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Persons encountering health services for examination and investigation

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Persons encountering health services for examination and investigation (Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints